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ABSTRACT 
The number of molecular diagnostic assays has increased tremendously in recent years. 
Nucleic acid diagnostic assays have been developed, especially for the detection of 
human pathogenic microbes and genetic markers predisposing to certain diseases. 
Closed-tube methods are preferred because they are usually faster and easier to 
perform than heterogenous methods and in addition, target nucleic acids are commonly 
amplified leading to risk of contamination of the following reactions by the 
amplification product if the reactions are opened. 
The present study introduces a new closed-tube switchable complementation probes 
based PCR assay concept where two non-fluorescent probes form a fluorescent 
lanthanide chelate complex in the presence of the target DNA. In this dual-probe PCR 
assay method one oligonucleotide probe carries a non-fluorescent lanthanide chelate 
and another probe a light absorbing antenna ligand. The fluorescent lanthanide chelate 
complex is formed only when the non-fluorescent probes are hybridized to adjacent 
positions into the target DNA bringing the reporter moieties in close proximity. The 
complex is formed by self-assembled lanthanide chelate complementation where the 
antenna ligand is coordinated to the lanthanide ion captured in the chelate. The 
complementation probes based assays with time-resolved fluorescence measurement 
showed low background signal level and hence, relatively high nucleic acid detection 
sensitivity (low picomolar target concentration). 
Different lanthanide chelate structures were explored and a new cyclic seven dentate 
lanthanide chelate was found suitable for complementation probe method. It was also 
found to resist relatively high PCR reaction temperatures, which was essential for the 
PCR assay applications. A seven-dentate chelate with two unoccupied coordination 
sites must be used instead of a more stable eight- or nine-dentate chelate because the 
antenna ligand needs to be coordinated to the free coordination sites of the lanthanide 
ion. The previously used linear seven-dentate lanthanide chelate was found to be 
unstable in PCR conditions and hence, the new cyclic chelate was needed. 
The complementation probe PCR assay method showed high signal-to-background 
ratio up to 300 due to a low background fluorescence level and the results (threshold 
cycles) in real-time PCR were reached approximately 6 amplification cycles earlier 
compared to the commonly used FRET-based closed-tube PCR method. The suitability 
of the complementation probe method for different nucleic acid assay applications was 
studied. 1) A duplex complementation probe C. trachomatis PCR assay with a simple 
10-minute urine sample preparation was developed to study suitability of the method 
for clinical diagnostics. The performance of the C. trachomatis assay was equal to the 
commercial C. trachomatis nucleic acid amplification assay containing more complex 
sample preparation based on DNA extraction. 2) A PCR assay for the detection of 
HLA-DQA1*05 allele, that is used to predict the risk of type 1 diabetes, was developed 
to study the performance of the method in genotyping. A simple blood sample 
preparation was used where the nucleic acids were released from dried blood sample 
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punches using high temperature and alkaline reaction conditions. The complementation 
probe HLA-DQA1*05 PCR assay showed good genotyping performance correlating 
100% with the routinely used heterogenous reference assay. 3) To study the suitability 
of the complementation probe method for direct measurement of the target organism, 
e.g., in the culture media, the complementation probes were applied to amplification-
free closed-tube bacteriophage quantification by measuring M13 bacteriophage 
ssDNA. A low picomolar bacteriophage concentration was detected in a rapid 20-
minute assay. The assay provides a quick and reliable alternative to the commonly used 
and relatively unreliable UV-photometry and time-consuming culture based 
bacteriophage detection methods and indicates that the method could also be used for 
direct measurement of other micro-organisms. 
The complementation probe PCR method has a low background signal level leading to 
a high signal-to-background ratio and relatively sensitive nucleic acid detection. The 
method is compatible with simple sample preparation and it was shown to tolerate 
residues of urine, blood, bacteria and bacterial culture media. The common trend in 
nucleic acid diagnostics is to create easy-to-use assays suitable for rapid near patient 
analysis. The complementation probe PCR assays with a brief sample preparation 
should be relatively easy to automate and hence, would allow the development of high-
performance nucleic acid amplification assays with a short overall assay time. 
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1 INTRODUCTION 
Molecular diagnostics (nucleic acid diagnostics) contains a broad range of 
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) assays. Nucleic acid based 
tests are used in a wide variety of applications, for example, in forensics to identify 
individuals 1, evolutionary studies to find phylogenetic relationships among 
organisms 2 and in environmental microbiology to monitor biodiversity 3. Clinical 
nucleic acid testing encompasses, for example, the search of genetic polymorphism 
related to hereditary diseases and detection of infectious microbial pathogens from 
various types of human samples 4, 5. Human pathogens are also searched in drinking 
and swimming water and in foodstuffs using nucleic acid assays 6, 7. In addition, 
molecular diagnostics is used for protein expression studies by measuring messenger 
RNA 8 and in pharmacogenomics, for instance, to analyze drug response in cancer 
therapy 9. 
Advances in genomics, especially the increased sequence data of different micro-
organisms and human genome due to the improvements in sequencing techniques and 
completion of the Human Genome Project in 2003 have led to the development of a 
huge number of clinical nucleic acid assays in the past 10 years. Many different 
technologies and assays have been established, especially for the detection of microbes 
causing infectious diseases and single-nucleotide polymorphism (SNP) related to 
genetic diseases. For example, the first United States Food and Drug Administration 
(FDA) approved nucleic acid based assay, the Legionnaires disease test performed in 
bacterial culture, was approved in 1986 10. The first nucleic acid amplification based 
test measured directly in a clinical sample, the Chlamydia trachomatis assay, was 
FDA-cleared in 1996 and in 2012 there were approximately 200 FDA-approved or 
cleared molecular diagnostic tests 11, 12. 
Molecular diagnostics of infectious diseases have several potential advantages 
compared to the traditionally used culture methods. Nucleic acid assays show high 
clinical specificity because detection is based on microbe-specific stable DNA 
sequences and high sensitivity is achieved by amplifying the target sequences. Nucleic 
acid tests enhance the detection of pathogens that are fastidious or uncultivable and this 
is also the case when the patient is treated with antibiotics before sample collection. 
The pathogen antibiotic resistance can be identified by detecting antibiotic resistance 
genes and in some diseases the severity of the condition can be estimated by the 
quantitative data. Theoretically, one of the main benefits of molecular diagnostics in 
infectious disease testing is short assay time. Results could be available in a few hours 
or even faster, whereas cultivation of the microbes requires several hours or even days 
of incubation. Rapid testing would be valuable especially in critical clinical situations, 
like in sepsis, where the pathogen identification is needed urgently for the initiation of 
a specific antimicrobial therapy. 13, 14 
Infectious disease testing represents the majority (70%) of the global molecular 
diagnostics market 14. Other commonly used nucleic acid assays are genetic tests 
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related, for example, to hereditary diseases and different type of cancers and 
approximately 25% of the FDA approved and cleared nucleic acid assays are human 
genetic tests such as breast cancer related HER2 tests. Recently, also companion 
diagnostics have become more common in the therapeutic product development. FDA 
has lately introduced guidelines that companion diagnostics should be used together 
with a novel therapeutic product to support the therapeutic product's safety and 
effective use 15. Companion diagnostics are used, especially in the development of 
personalized drugs that have effect only on specific patient population having a 
particular genotype. The trend of personalized medicine is growing and thus, also the 
need of companion diagnostics. 9 
Although molecular diagnostic technologies have shown superior features compared 
to the conventional culture-based methods in infectious disease diagnostics, the 
traditional phenotypic methodologies such as culture and staining are still the 
principal methods. Basically, nucleic acid assays are rapid but they often require 
relatively complex and laborious sample preparation and reagent handling requiring 
experienced personnel and long hands-on time. There are automated systems, for 
example, for the detection of infectious diseases 16 but the current sophisticated 
instrumentation significantly increases the assay costs and the automated systems 
still usually have several hours turnaround time. In routine clinical diagnostics 
nucleic acid technologies are nowadays more commonly used in virus diagnostics 
than for bacteria detection. The virus tests have been developed mainly because 
culture based virus assays are more complex, laborious and time-consuming to 
perform than bacteria culturing because a virus requires a host organism for 
reproduction further complicating the assay protocol. Nowadays, clinical bacterial 
nucleic acid assays are mainly used to either confirm culture results and or the 
detection of uncultivable or fastidious bacteria. 13, 17 18 
In the future, molecular diagnostics will be increasingly adapted to routine clinical 
diagnostics. But before becoming more commonly used, for example, in infectious 
disease diagnostics, more multiplexed, cost-effective, easy-to-use and even faster 
assays must be prepared. Multiplexed assays should be able to detect multiple 
pathogens and resistant markers from one sample in one assay. This would shorten the 
total analysis time and also decrease the costs. Assays should be automated containing 
also the sample preparation. Multiplexed nucleic acid amplification assays are already 
available 4, 19 but one of the main disadvantages of the mainly used multiplexed 
technologies is that they require post-amplification sample handling increasing the 
assay time and also causing risk of amplification product cross-contamination. In 
coming years, the greatest impact of the molecular diagnostics will most likely be in 
the development of closed-tube point-of-care (POC) infectious disease assays with 
rapid turnaround time where the results are available in less than one hour or even in 
30 minutes. 20-22 
In this thesis, a new high-performance homogenous polymerase chain reaction (PCR) 
assay concept is described. The introduced system is based on switchable lanthanide 
fluorescence probe technology where the fluorescence is “turned on” in the presence 
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of a specific nucleic acid target. Functionality of the system is demonstrated by 
clinical diagnostic assays and amplification free bacteriophage quantitation assay 
based on the new technology. The presented technology also opens up possibilities 
for the development of a highly multiplexed homogenous molecular diagnostic 
platform. 
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2 LITERATURE REVIEW 
2.1 Fluorescent labels in homogenous nucleic acid assays 
Homogenous nucleic acid assays most commonly utilize fluorescence-based detection 
methods. Fluorescence methods are widely used mainly because of the high sensitivity 
of the fluorometric techniques and also because fluorescent labels are not as hazardous 
as traditionally used radioisotope labels 23. 
Fluorescence is a particular type of luminescence, more precisely a type of 
photoluminescence (Table 1). In general, it is a physical effect resulting from 
excitation of a fluorescent molecule by absorption of a photon followed by de-
excitation as emission of a photon. The absorption of a photon by a molecule in the 
ground state leads to the transition of an electron from its original orbital to an 
unoccupied orbital and thus, to the excitation of the molecule. The excitation is relaxed 
by emission of a photon at a higher wavelength (lower energy) than that of the 
absorbed photon. The change in wavelength occurs because part of the energy is lost in 
the excited state mainly by the vibrational relaxation. 24  
Table 1. Different luminescence types 24. 
 
Phenomenom 
 
Mode of excitation 
Photoluminescence (fluorescence, phosphorescence, 
delayed fluorescence) 
Absorption of light (photons) 
Radioluminescence Ionizing radiation (X-rays, α, β, γ) 
Cathodoluminescence Cathode rays (electron beams) 
Electroluminescence Electric field 
Thermoluminescence Heating after prior storage of energy (e.g. 
radioactive irradiation) 
Chemiluminescence Chemical process (e.g. oxidation) 
Bioluminescence Biochemical process 
Triboluminescence Frictional and electrostatic forces 
Sonoluminescence Ultrasounds 
 
A good fluorescent reporter molecule possesses several characteristics. High molar 
absorptivity and high quantum yield are required for efficient fluorescence signal 
generation. The quantum yield is the ratio of the number of photons emitted as 
fluorescence to the total number of absorbed photons and molar absorptivity refers to 
the ability of the molecule to absorb excitation light at a particular wavelength. A large 
Stokes shift and narrow excitation and emission spectra are beneficial because 
overlapping excitation and emission spectra leads to self-quenching of the fluorescence 
when a fluorophore is used at high concentration. Overlapping spectra with a small 
Stokes shift may hinder fluorescence measurement because the use of excitation and 
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emission wavelengths too close to each other can lead to direct measurement of the 
excitation light. In addition, a large Stokes shift is advantageous for reducing 
autofluorescence measurement that usually have a small Stokes shift. A long excited-
state lifetime usually called as long fluorescence lifetime can be advantageous for 
reducing the assay's background signal level. The background signal can be decreased 
by measuring the long-lived sample fluorescence after a short lifetime background 
signal eliciting mainly from the sample containing autofluorescent material and from 
the plastic reaction vessel has decayed. A high fluorophore stability is also an 
important feature as, for example, a fluorophore should be resistant to multiple 
excitation events without degradation to avoid so called photobleaching and 
thermostability is needed in a particular type of assays where high reaction 
temperatures are used. 25 
2.1.1 Organic fluorophores 
Synthetic organic fluorophores are the most common reporter molecules in 
homogenous nucleic acid assays, for example, in closed-tube PCR assays. These 
fluorescent dyes mainly consist of conjugated cyclic structures, i.e., aromatic groups. 
Various organic molecules containing aromatic groups are fluorescent but only a 
fraction of them show high fluorescent intensity suitable for diagnostics. Fluorescent 
properties of aromatic compounds are difficult to predict and traditionally many of the 
common fluorophores have been empirically discovered rather than intentionally 
developed. Although nowadays, at least new derivatives of previously presented 
fluorophores can be produced by design. 26, 27 
Several fluorophores with different excitation and emission spectra are used in 
molecular diagnostics. Different fluorescent molecules are based on different 
conjugated basic structures. For example, fluorescein, one of the oldest fluorophore 
synthesized in 1871 by Adolf von Baeyer, and its derivate the 6-carboxyfluorescein (6-
FAM) are based on the xanthene scaffold as well as the rhodamine B and also 
rhodamine derivates such as the 5-TAMRA and the Texas red. Another widely used 
group of fluorophores is based on cyanine structure, such as, the Cy3, Cy5 and Sybr 
Green I. 27-29 Typical organic fluorophore structures are illustrated in Figure 1. 
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Figure 1. Examples of organic fluorescent molecules used in molecular diagnostics. Molecular 
structures of (1) fluorescein (3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one); (2) 
rhodamine B ([9-(2-carboxyphenyl)-6-(diethylamino)xanthen-3-ylidene]-diethylazanium); (3) Cy3 
(2-[(E,3Z)-3-(1,3-dihydroindol-2-ylidene)prop-1-enyl]-3H-indol-1-ium); (4) Cy5 (2-[(1E,3E,5Z)-5-
(1,3-dihydroindol-2-ylidene)penta-1,3-dienyl]-3H-indol-1-ium); and (5) Sybr Green I (N,N-
dimethyl-N'-[4-[(E)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]-1-phenylquinolin-1-ium-2-yl]-
N'-propylpropane-1,3-diamine). 
Absorption of a photon by a fluorophore in the ground state (ground state usually 
denoted by S0) leads to the transition of an electron and excitation of the fluorophore to 
the singlet excited state (S1). Conjugated structures have delocalized electrons in π-
orbitals and the excitation energy mainly promotes π-electron transition to the higher 
vibrational level usually described as π→π* transition. Two electrons in the orbital of a 
molecule in a ground state have opposite spins and excitation to the higher energy state 
S1 does not effect the spins. The energy of an electron in the S1 state is released as 
emission of a photon (fluorescence) when the electron returns to the S0 state. 30 
A wide variety of organic fluorophores with different excitation and emission 
maximum wavelengths suitable for different kind of assay set-ups, for example, 
multiplexed assays containing several fluorophores in one reaction, are easily 
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available. Organic fluorophores commonly show strong fluorescence emission with a 
high quantum yield, even nearly 100% in optimal reaction conditions. 30, 31  
Fluorescence lifetimes of organic fluorophores are short, typically, from 1 to 10 ns. 
Lifetimes are relatively short because fluorophores stay in the excited state only during 
rapid de-excitation processes like vibrational relaxation of an electron from the higher 
excited states (e.g. denoted by S2) to the excited state S1. 30 
Fluorescence measurements in nucleic acid diagnostics mainly utilize the most 
common type of fluorescence measurement, the so called steady-state measurement. In 
steady-state measurement a fluorophore is constantly excitated while emission is 
simultaneously measured and thus, it is a suitable method especially for the 
measurement of short lifetime fluorescence. This type of measurement can be 
performed very fast and high fluorescence emission can be detected. However, organic 
fluorophores usually have a small Stokes shift and thus, the fluorescence detector must 
be able to precisely detect only the emission signal at a specific wavelength to avoid 
direct measurement of the excitation light. Organic fluorophores also have wide 
overlapping excitation and emission spectra and this must be considered when 
designing multiplexed assays. In addition, autofluorescence from a biological sample 
material has also nanosecond lifetime and autofluorescence can increase the 
background signal level and thus, decrease assay sensitivity. 30, 32 Typical emission and 
excitation spectra of organic fluorescent molecules are shown in Figure 2. 
 
Figure 2. Typical excitation and fluorescence emission spectra of organic fluorophores. 
Excitation (dashed line) and emission (solid line) spectra of the fluorescein isothiocyanate 
(blue), rhodamine 6G (green) and cy3 (orange) by Molecular Probes® (Life Technologies 
Corporation, CA, USA). 
2.1.2 Lanthanide chelates 
The lanthanides consist of 15 chemical elements belonging to the group of the rare 
earth metals. Most of the lanthanide ions (LnIII) are luminescent but europium and 
terbium clearly possess the highest fluorescent intensity and the longest excited-state 
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lifetime, lasting even up to milliseconds. In addition, also samarium and dysprosium 
show suitable fluorescent properties (intensity and lifetime) and the chelated EuIII, 
TbIII, SmIII and DyIII have been used in several fluorescence-based assay applications 
since the introduction of the lanthanide-based immunoassays by the Finnish 
researchers in the late seventies. 33, 34 
The fluorescent lanthanide chelates possess unique fluorescent properties such as large 
Stokes shifts, long fluorescence lifetimes and sharp ion specific emission profiles. The 
fluorescence properties of the lanthanide elements originate from their exceptional 
electron configuration that differs from the main group elements. The lanthanides are f-
block elements having electrons in the f orbital and the fluorescence occurs mainly 
from the electron transitions in the 4f orbital, denoted by 4f*→4f transition. The 4f-
orbital is shielded by the filled 5s and 5p orbitals resulting in the characteristic narrow 
emission profiles of the lanthanides. 30, 35-37 
The fluorescent lanthanide ions show unique features valuable for diagnostic assays 
but because of their low molar absorption coefficients (< 1 M-1 cm-1) the f→f* 
transition by direct excitation is very poor and they require a surrounding organic 
chromophore structure also called an antenna or a ligand, for the excitation process. In 
addition, H2O effectively quenches the fluorescence of the LnIII by the non-radiative 
relaxation via O–H oscillation of the water molecules coordinated to the lanthanide 
ion. The organic chromophore chelated to the LnIII absorbs the excitation energy and 
transfers the energy to the ion, and because the chromophore is coordinated to the LnIII 
it also efficiently prevents fluorescence quenching caused by the H2O. 24, 38 Typical 
excitation and emission spectra of chelated terbium and europium ions 39 are shown in 
Figure 3. 
  
Figure 3. Typical excitation (grey, dashed line) and emission (black) spectra of terbium (A) and 
europium (B) chelates 39. 
The excitation of LnIII by intramolecular energy transfer using an organic chromophore 
was first reported 1942 by Weissman 40 and since then a large number of different 
chromophore structures have been synthesized and studied, especially in the past few 
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decades. Commonly used chromophores usually contains variable numbers of aromatic 
pyridine groups with substituents such as β-diketones and carboxylic acids 41. An 
effective antenna must be able to absorb the excitation energy and effectively transfer 
the energy to the LnIII. A wide study of the fluorescence properties of 41 different EuIII 
and TbIII chelates was published in 1997 by Latva et al. 42 and recently, a 
comprehensive review article related to the LnIII chromophores was published by 
D’Aléo et al. 38. 
The LnIII excitation process starts with the excitation of the antenna as an electron 
migrates from the ground state S0 to the singlet excited state S1. Then the chromophore 
undergoes a spin conversion to the triplet state (T1) in the process called intersystem 
crossing. Finally, the LnIII is excited by the intramolecular energy transfer where the 
energy is transferred from the T1 to the f orbital resonance level of the LnIII (T1→f*), 
and the energy can be emitted as lanthanide ion fluorescence (f*→f). For successful 
excitation of the LnIII the chromophore should fill several requirements. The antenna 
should show minimal radiative and nonradiative transitions in the S1 and T1 states and 
the LnIII antenna complex should not elicit an energy back transfer from excited LnIII to 
the antenna. 30, 42, 43 One of the key factors is also the triplet state energy level of the 
antenna because different lanthanide ions have different lowest excited levels and 
generally it is stated that the highest quantum yield is achieved when energy is 
transferred from the antenna´s lowest triplet state level to the lowest excited level of 
the LnIII. However, there are also results showing that when the triplet state level is too 
close to the lowest excited level of the LnIII the fluorescence is decreased and in fact, 
more powerful fluorescence is achieved when a chromophore with a slightly higher 
triplet state energy level is used. 42 For example, the main emission level of the EuIII , 
i.e., its lowest excited state, is 5D0 but, as described by Latva et al. 42, a higher intensity 
EuIII fluorescence is achieved when an antenna with the triplet state energy level higher 
than the EuIII resonance level 5D1 or even higher than 5D2 is used. It is also shown that 
different type of antenna structures give out the largest EuIII quantum yield on different 
energy levels, for example, for β-diketones this occurs close to 5D1 level and for 
polyaminocarboxylates near 5D2 level 34. 
The LnIII excitation through the chromophore's triplet state (S1→T1→LnIII) was shown 
in the early 1960s by Crosby et al. 44 and it is a generally and widely accepted theory. 
However, also other LnIII excitation pathways have been presented and thus, in 
addition to the antennas triplet state energy level there most likely are also other 
important factors in the excitation process. One alternative excitation route, a direct 
energy transfer from S1 to the LnIII, was first described as early as 1969 by Kleinerman 
45 but most of the practical studies have been focused on the triplet state excitation 
process. However, the singlet excited state pathway has recently raised interest and, for 
example, Yang et al. 46 have discovered a EuIII chelate complex utilizing singlet state 
excitation route. The antennas using singlet state excitation route can be excited with a 
light emitting diode (LED)-based light source using wavelengths over 365 nm, whereas 
LnIII excitation through the triplet state pathway usually requires UV-excitation by 
xenon or laser light sources. The LED excitation would allow the usage of simpler, 
smaller and cheaper instruments. 
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The LnIII excitation through triplet state using higher wavelengths, therefore requiring 
lower energy, is mentioned to be limited to about 346 nm for TbIII and 385 nm for EuIII 
by the main fluorescence emission levels of the TbIII (5D4 20400 cm-1) and EuIII (5D0 
17500 cm-1) 47. The main emission levels set the limit because, for example, the stated 
theoretical maximum EuIII excitation wavelength of 385 nm is equal to 25974 cm-1 and 
it is assumed that the energy cap between the antenna's singlet and triplet state is at 
least 5000 cm-1 and that the triplet state energy must be at least 3500-1 cm higher than 
the LnIII main emission level 47. 
In conclusion, the LnIII excitation pathways are not yet completely understood and 
thus, the design of efficient LnIII chromophores still requires plenty of experimental 
work. On the other hand, in the future we can hopefully design new lanthanide chelates 
with even better fluorescent properties. Excitation energy transfers through the 
antenna's triplet state and by the direct excitation from S1 to LnIII are illustrated in 
Figure 4.  
 
Figure 4. Jablonski diagram illustrating two possible LnIII excitation route: intramolecular 
energy transfer through the chromophore's triplet state (T1) and direct energy transfer from the 
chromophore's singlet state (S1) to the LnIII. LnIII excited state denoted by 4f* and also TbIII and 
EuIII main emission levels 5D4 and 5D0 are showed, respectively. 
Despite of the unique fluorescence properties, lanthanide chelates have only rarely 
been used as fluorescent reporters in homogenous nucleic acid assays, such as, closed-
tube PCR. One of the main obstacles is that there is no commercially available PCR 
thermal cycler containing suitable measurement instrument for lanthanides which 
would be compatible with standard laboratory reaction vessels. However, in the past 
decade lanthanide chelate-based homogenous PCR assays have been presented, for 
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example, for the detection of human pathogens 48, 49, quantification of prostate specific 
mRNA levels in prostate cancer diagnostics 50, 51, and for the detection of single-
nucleotide-polymorphism related to genetic disorders 52-54. In addition, it has been 
shown that long lifetime lanthanide fluorescence with time-resolved measurement can 
be advantageous in homogenous PCR assay to the analysis of biological samples 
containing autofluorescent residues 48, 52. 
Assays performed in high temperatures, such as part of the PCR steps, require a stable 
lanthanide chelate structure. The lanthanide ion can form nine coordination bonds 55 
with the nitrogen and oxygen atoms 56. Lanthanide chelates with maximum number of 
coordination bonds form stable structures able to keep LnIII chelated even in high 
temperatures. In addition, LnIII coordination to an organic chelate effectively prevents 
H2O coordination to the LnIII and thus, prevents the H2O quenching effect. 
Homogenous PCR assays have been reported to base on intrinsically fluorescent 
nonadentate EuIII or TbIII chelates that elicit quantum yields from 13% to 18% 6, 48, 49, 51, 
57. The structures of the lanthanide chelates used in PCR are illustrated in Figure 5. 
 
Figure 5. Molecular structures of the intrinsically fluorescent lanthanide chelates used in 
homogenous PCR. References and systematic names for structure (1) {2,2',2'',2'''-{ [2-(4-
isothiocyanatophenyl)-ethylimino]bis(methylene)bis{4-{[4-(α-galactopyranoxy) phenyl]ethynyl} 
pyridine-6,2-diyl}bis(methylenenitrilo)}tetrakis(acetato)}europium(III) 58; (2) {2,2',2'',2'''- 
{[2-(4-isothiocyanatophenyl)-ethylimino]bis(methylene)bis{4-[2-methoxy-4-(carboxymethoxy)  
phenyl]pyridine-6,2-diyl}bis(methylenenitrilo)}tetra kis(acetato)}terbium(III) 59; and (3) {2,2',2'',2'''-
{{6,6'-{4''-[2-(4-isothiocyanatophenyl)ethyl]pyrazole-1'',3''-diyl}bis(pyridine)-2,2'-diyl}bis  
(methylenenitrilo)}tetrakis (acetato)}terbium/europium(III) 60, 61. 
Furthermore, homogenous nucleic acid detection based on sub-micrometer-sized 
upconverting phosphor (UCP) particles consisting of ytterbium and erbium lanthanides 
among sodium yttrium tetrafluoride has been introduced 62. The luminescent properties 
of the UCPs could be advantageous in nucleic acid diagnostics but nucleic acid 
amplification assays based on UCPs have not been presented and thus, neither the 
upconverting phosphor particles nor another fascinating particulate dye, the europium 
chelate-doped nanoparticles, are introduced in more detailed. 
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2.1.2.1 Time-resolved measurement 
Lanthanide chelates elicit long lifetime fluorescence and thus, time-resolution can be 
advantageous in fluorescence signal measurement. In time-resolved measurement, 
pulsed excitation is followed by a delay before the signal counting. During the delay 
the signal is not measured and autofluorescence, for example, from the plastic reaction 
vessel and biological sample is decayed. 63 In a typical EuIII time-resolved 
measurement a delay of 400 µs is used after the excitation and the fluorescence is 
counted from 400 to 800 µs. This cycle is repeated 1000 times during a total 
measurement time of approximately 1 s. A fluorometer for time-resolved measurement 
usually contains conventional fluorometer components and additionally, a 
measurement unit capable of time-gated measurement. The principle of the time-
resolved measurement is illustrated in Figure 6. 
 
Figure 6. Schematic presentation of fluorescence measurement in time-resolved mode. 
Modified from the reference 63. 
2.2 Nucleic acid amplification methods and sample 
preparation 
Nucleic acid diagnostics are based on the analysis of the nucleic acid, either DNA or 
RNA. Most of the assays include a nucleic acid amplification step because, for 
example, human, food and environmental samples rarely contains enough nucleic acids 
for direct measurement with commonly used techniques. In vitro amplification 
methods used in the molecular diagnostics typically share two basic features: 
amplification is initiated by the hybridization of a target-specific oligonucleotide called 
primer, and the target nucleic acid is enzymatically amplified. The amplification of the 
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target nucleic acid enables the detection of even fewer than 10 target copies in one 
reaction making the assays highly sensitive 64, 65. 
Several amplification techniques have been developed in the past two or three decades. 
The polymerase chain reaction was introduced in 1985 66, 67 and it is still the most 
commonly used nucleic acid amplification technique. PCR is very efficient 
amplification method resulting in exponential target DNA replication. The principle of 
the PCR is illustrated in Figure 7. PCR is a widely used method but it requires 
temperature cycling typically from 50–60 °C to almost up to 100 °C by a specific 
instrument called PCR thermocycler. Lately, there has been increasing interest for 
assays based on isothermal nucleic acid amplification. There are several isothermal 
amplification methods and all of these techniques are performed in a constant 
temperature, although, a part of these methods requires an initial denaturation step at a 
high temperature. Isothermal amplification reactions are simpler and cheaper to 
perform than PCR, and therefore, more suitable especially for point-of-care and lab-on-
a-chip type diagnostics. Furthermore, at least three methods (LAMP 68, NASBA 69 and 
SDA 70) have shown DNA amplification performance comparable to PCR. 65 The main 
isothermal amplification methods are introduced in Table 2. 
 
Figure 7. Principle of the polymerase chain reaction (PCR). The target DNA (long thick 
arrows) is denatured at high temperature and the oligonucleotide primers (short thick arrows) 
are hybridized to the two target strands when the temperature is decreased (annealing step). 
DNA polymerase synthesizes new strands by incorporating nucleotides to the primers according 
to the template strand sequence (extension step). In each amplification cycle the number of 
target DNA sequences is doubled. The arrowheads indicate the 3’ end of the nucleic acids. The 
flow of the PCR is indicated by the thinner arrows. Modified from the reference 64. 
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In addition to the isothermal nucleic acid amplification methods replicating the target 
sequence, there are also isothermal amplification methods that are called signal 
amplification methods. These methods such as, the branched DNA 81 , beacon assisted 
detection amplification 82, and Q-beta replicase 83 are generally based on probe 
amplification initiated by the target nucleic acid. 
Enzymatic amplification of the nucleic acids is a relatively sensitive process and can be 
interfered with the impurities in the analyzed sample. Different type of samples such 
as, body fluids, foodstuffs and environmental samples contain amplification inhibitors. 
For example, hemoglobin and urea in blood and urine, respectively, and many organic 
and phenolic compounds in food samples can inhibit the amplification reaction. Many 
inhibitors have been indentified but the inhibition mechanisms have not been widely 
studied and they have mainly remained unclear. To remove the inhibitors sample 
pretreatment methods are used before the amplification. 84 Although, sample 
preparation before the amplification is an essential part of the nucleic acid assays, it is 
only slightly reviewed in this thesis. 
Nucleic acid assay sample preparation is commonly based on nucleic acid extraction 
containing a variable number of different steps such as target (e.g., bacteria or virus) 
concentration/separation, nucleic acid liberation, and nucleic acid purification steps. 
Target concentration is needed in assay applications where the sample might contain 
only few target particles. For example, body fluids, such as blood, rarely contain high 
concentrations of infectious microbes. It must also be considered that the sample might 
contain other components that might inhibit the amplification, e.g., red blood cells in 
blood samples, and these should not be concentrated along with the target particles. 
Concentration can be performed, for example, by centrifugation, filtration or using 
antibody-based bacteria capture 48, 85-87. In some applications bacterial culture prior to 
the PCR analysis is used 49. 
Nucleic acids need to be released from the target organism before the amplification and 
the simplest method is to lyse the target cells in the PCR by the high temperature of the 
initial PCR denaturation step. 48, 88 Unfortunately, the heat treatment disrupts only some 
of the gram-negative bacteria and mammalian cells but the high temperature does not 
lyse effectively, for example, most of the gram-positive bacteria and yeast cells. 
Therefore, the disruption of the cells has been achieved by different mechanisms such 
as mechanical lysis using glass or metal beads together with vortexing, chemical lysis 
by NaOH, sonication and enzymatic lysis. 89, 90 
After the disruption of the cells the liberated nucleic acids are commonly purified 
because lysed bacteria residues might interfere with some of the homogenous 
fluorescence-based detection methods and also amplification. Purification is usually 
performed using solid phase extraction techniques. The main method is based on silica 
solid phase that effectively binds nucleic acids in chaotropic salt solution. While bound 
to the solid phase the nucleic acids can be washed effectively and then eluted in 
aqueous buffer. 91 Another solid phase method is based on capture probes that 
specifically hybridize to the target nucleic acid. Nucleic acids can be removed from the 
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capture probes by denaturing the hybrid in high temperatures, or the nucleic acids can 
be amplified directly on the solid phase. 92 
Sample preparation commonly contains multiple steps and therefore, it is time-
consuming to perform requiring experienced personnel. Automation decreases hands-
on-time but current automated systems are usually complex, relatively expensive, and 
not suitable for miniaturized and rapid near-patient diagnostics. One alternative for 
complex sample preparation is to create more robust nucleic acid assays that require 
only minimal sample preparation. The robustness of the assay can be increased, for 
example, by using DNA polymerase that tolerates inhibitors allowing the use of 
samples without DNA purification 93. Additionally, lanthanide chelates and time-
resolved fluorescence measurement (TRF) have been used in a PCR assay with simple 
sample preparation to avoid the measurement of autofluorescence 48, 52. 
2.3 Fluorescence-based homogenous nucleic acid 
detection methods 
Different organisms can be identified using nucleic acid assays detecting organism 
specific genetic material either DNA or RNA. Most of the assays are based on nucleic 
acid amplification and simultaneous i.e. real-time or post-amplification detection. 
Nucleic acid detection technologies can be divided, for instance, to heterogenous and 
homogenous, i.e., closed-tube methods. 
In heterogenous assays the target nucleic acids are first amplified. Then the amplified 
nucleic acids are commonly captured to the solid-phase and detected, for instance, by 
using fluorescent oligonucleotide probes. Solid-phase capturing allows highly 
multiplexed detection because different sequences can be detected in one reaction 
chamber based on spatial differentiation. Assays based on heterogenous detection are 
widely used but they require post-amplification sample handling that increases assay 
time, complexity and especially the risk of amplification product cross-contamination. 
Furthermore, the heterogenous methods are not suitable for quantification because the 
amount of extensively amplified nucleic acids is not directly proportional to the initial 
amount. 
Assays based on homogenous detection methods are more difficult for multiplexing 
but, in general, they are easier to use and faster compared to heterogenous methods, 
and they have low contamination risk. 4, 94 Homogenous methods allow target nucleic 
acid quantification by measuring the signal in real-time during the amplification, for 
example, in PCR after every amplification cycle. In real-time quantitative PCR (qPCR) 
target amount quantification is generally performed by determining the threshold cycle 
(Ct), also called the quantification cycle (Cq) 95 and calculating the target concentration 
using a known standard. The threshold cycle is the PCR amplification cycle where the 
signal exceeds the background signal level, more precisely a threshold signal level that 
is a statistically significant point above the background level. 95, 96 Homogenous 
methods can also be used for qualitative measurement; for example, a simple 
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qualitative so called end-point PCR can be performed by measuring the signal only 
after the PCR amplification 97, 98. 
Several different homogenous nucleic acid detection methods suitable for qualitative 
and quantitative measurements have been developed during the past two decades. The 
term fluorophore in the method descriptions below refers to the common organic 
fluorophores if not otherwise mentioned. 
2.3.1 Non-sequence-specific detection methods 
DNA intercalative dyes 
Some of the organic fluorophores are environmentally sensitive and their fluorescence 
can be decreased, for example, by an aqueous solvent. Intercalation to the DNA changes 
the fluorophore’s microenvironment leading to an increased fluorescence signal of 
certain fluorophores. 24, 99 The first method for homogenous detection of amplified 
nucleic acid was based on DNA intercalative ethidium bromide (EtBr) and published in 
1992 100. The ethidium bromide shows high DNA binding affinity and when intercalated 
to the double-stranded DNA (dsDNA) the fluorescence of the EtBr is increased 101. The 
fluorescence intensity of the EtBr is proportional to the amount of DNA and therefore, 
EtBr is suitable for real-time quantitative measurement of the amplified nucleic acids. 
Later on, the EtBr was replaced with the less PCR-inhibitory and less carcinogenic Sybr 
Green I that has since become a popular dye in the PCR diagnostics. 102 Intercalative 
dyes can be used together with any amplification method that produces double-stranded 
nucleic acids. They are not sequence specific and thus, false amplification products, e.g., 
primer dimers increase fluorescence signal and can lead to false positive results. 
However, specificity of the intercalative-dye-based assays can be increased by using a 
melting curve analysis where different sized amplification products are differentiated. 103  
Multiplexed detection in one reaction solution is not possible using intercalative dyes 
with different emission spectra, but multiplexed assays based on intercalative dyes 
have been sucesful when using a melting curve analysis 103, 104. An automated platform 
for the detection of 21 respiratory pathogens has recently been published and also 
FDA-approved (510(k) number, K123620); it is based on homogenous PCR and DNA 
intercalative dye and also contains integrated sample preparation. The system is based 
on nested two-step PCR where several different primers are used. The second 
amplification step is performed in separated reaction chambers where different targets 
are amplified in specific reaction vessels and after the amplification, detection is 
performed using melting temperature analysis. 105 The multiplexed homogenous 
respiratory pathogen assay represents the common trend but also brings out the 
common problem of the multiplexed assays showing relatively high limit of detection 
of part of the target microbes. 
DNA-assisted excimer formation 
The DNA-assisted excimer formation is based on cyclophane interaction with DNA 
leading to excimer formation. The excimer is a dimer with associated excited 
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electronic state and the excimer formation can be observed as an emission shift to 
longer wavelengths compared to the monomer emission. Neelakandan and Ramaih 106 
have introduced a cyclophane derivative that does not interact with proteins but binds 
to the DNA by the weak interaction, e.g., hydrophobic and electrostatic interactions 
leading to excimer formation and emission maximum wavelength shift from 430 nm to 
570 nm and a relatively long fluorescence lifetime of approximately 143 ns. 30, 106, 107 
Bioluminescence-based techniques 
Bioluminescence is a form of chemiluminescence where a chemical reaction produces 
light and thus, it is not fluorescence. However, a recently presented innovative 
homogenous bioluminescence-based nucleic acid detection method is introduced here. 
Bioluminescent Assay in Real-Time (BART) is based on isothermal LAMP 
amplification, ATP sulfurylase and thermostable firefly luciferase enzymes. During the 
nucleic acid amplification inorganic pyrophosphate (PPi) is produced and the PPi is 
converted to adenosine triphosphate (ATP) by the ATP sulfurylase. The luciferase 
enzyme produces light in a reaction where the ATP is needed for the oxidation of the 
luciferin substrate. The BART assay should be a suitable method for low-cost nucleic 
acid amplification assays because only a simple instrument containing a light detector 
and producing a constant temperature is needed. 108 
2.3.2 Sequence-specific detection methods 
Sequence-specific detection methods are generally based on the fluorescence signal 
modulation by the oligonucleotide probe hybridization to the target sequence. Nucleic 
acid amplification assays utilizing sequence-specific methods are highly specific 
because they are dependent on both the primer(s) and the probe(s) hybridization to the 
target sequence. Methods based on sequence-specific oligonucleotide probes allow 
multiplexing, for example, by using probes labeled with different fluorophores 109. 
2.3.2.1 FRET-based hybridization methods 
The mainly used homogenous sequence-specific detection methods are based on 
Förster resonance energy transfer (FRET) 110. The FRET is a nonradiative energy 
transfer process of the excited-state energy from an excited fluorescent donor molecule 
to an acceptor molecule leading to the excitation of the acceptor. The energy is 
transferred through long range dipole-dipole interactions between the donor and 
acceptor and does not involve emission and reabsorption of a photon. The excited 
donor is relaxed to the ground state and the acceptors excitation can be observed as 
fluorescence if the acceptor is a fluorescent molecule. The FRET requires donor and 
acceptor with similar resonance frequencies, and in practice this means that the donor's 
emission and acceptor's absorption spectra must overlap. Another requirement is the 
short distance, from 1 to 10 nm, between the donor and acceptor. 24, 30 In homogenous 
nucleic acid assays fluorescent and non-fluorescent acceptors have been used. Several 
sequence specific FRET-based methods are listed in Table 3, and they are described 
below in more detail. 
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Table 3. Homogenous sequence specific FRET-based nucleic acid detection methods. 
 
Method 
 
 
Principle 
Hydrolysis probe 111, 112 5´ nuclease technology 
Snake 113  
Attached universal template probe 114  
Universal hydrolysis probe  115  
Universal AEGIS hydrolysis probe 116  
Molecular beacon 117 Molecular beacon hairpin method 
Amplifluor 118  
Scorpion 119, 120  
UniPrimer 121  
Universal Molecular Beacon (U-MB) 122  
Mediator probe 123 Other 
FRET probes 102  
Competitive hybridization 124  
Competitive hybridization and Hydrolysis probe 57  
QZyme 125  
NuPCR,126  
MagiProbe 127  
Invader128  
Lion probe 129  
Single-quantum-dot-based DNA nanosensor 130  
Hydrolysis probe 
The Hydrolysis probe technology was introduced in 1991 and it was the first sequence 
specific detection method used in homogenous nucleic acid amplification assay and it 
is also known as the 5´ Nuclease technology and as the TaqMan technology. One 
oligonucleotide probe is dual labeled with a fluorophore in one end and a quencher in 
the other. The fluorescence of the intact probe is quenched because the fluorophore and 
quencher are in close proximity. During the PCR amplification the probe is hybridized 
to the target sequence and degraded by the Thermus aquaticus (Taq) DNA polymerase 
5´ nuclease activity while the new strand is amplified. When the probe is degraded the 
distance between the fluorophore and quencher increases releasing the quenching and 
increasing the signal. 111, 112, 131 (Figure 8) 
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Figure 8. Principle of the Hydrolysis probe technology. The hybridized dual end-labeled 
Hydrolysis probe is degraded by the DNA polymerase enzyme (grey oval) during the PCR 
amplification. Increase in fluorescence signal is observed when the distance between the 
fluorophore (white circle) and quencher (black circle) increases and hence, the quenching 
efficiency decreases. Modified from the reference 132. 
The Hydrolysis probe technology is the most commonly used homogenous nucleic acid 
detection method, and several modified applications based on the DNA polymerase 5´ 
nuclease activity have been developed. A Snake method was introduced in 2010 and 
showed to improve the dual labeled probe degradation and therefore, the fluorescence 
signal generation 113. In the Snake system a so called snake primer contains a 5´ 
overhang sequence (called flap sequence) that does not hybridize to the target sequence 
but is incorporated into the PCR product when the Snake primer is elongated. 
Consequently, the complementary strand contains the flap sequence at the 3´ end. After 
denaturation of the amplified product the 3´ end of the amplified strand self-hybridizes 
forming a hairpin structure and one unhybridized nucleotide mismatch at the 3´ end. A 
dual labeled Hydrolysis probe hybridizes next to the self-hybridized sequence. This 
structure is an optimal substrate for 5´ nuclease activity of the Taq polymerase and 
results in a more effective 5´ nuclease cleavage of the probe than the original 
Hydrolysis probe technology. 
Preparation of target-specific probes involves relatively laborious and costly research 
and development work, especially when preparing assays for several different targets. 
To simplify assay development 5´ nuclease activity based sequence-specific, so-called 
universal detection methods have been introduced. The universal methods enable usage 
of a single probe for the detection of several different targets in different reactions. 
Several methods utilize a primer with a 5´ overhang sequence that incorporates a 
universal Hydrolysis probe detection sequence into the amplicon. During the PCR 
amplification a universal dual labeled probe hybridizes to the incorporated sequence 
and is degraded by the DNA polymerase 5´ nuclease activity 114-116. In addition, to 
enhance the 5´ nuclease activity Moser et al. 116 incorporated an adjacent isoguanosine 
(iG) and isocytidine (iC) into the 5´ overhang sequence. The artificial nucleotides are 
not correctly amplified by the DNA polymerase. Instead, misincorporation occurs 
opposite to the iG and the amplification is terminated to the adjacent iC resulting in an 
unpaired 3´ single base flap and, because of the termination also a single-stranded 5´ 
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overhang in the opposite strand. A dual labeled universal probe hybridizes to the 
overhang next to the 3´ single base flap creating a double-flap gap substrate for the flap 
endonuclease activity that is mentioned to be part of the DNA polymerase 5´ nuclease 
133. The flap endonuclease cleaves off the fluorophore labeled 5´ flap nucleotide of the 
probe. Universal detection systems enable the use of the same detection probe in 
different assays because the detection sequence for the probe is added to the amplicon 
by the primer elongation and therefore, the target sequence can easily be incorporated 
into different primers. Unfortunately, universal primer-based systems are prone to false 
positive results if unspecific primer amplification occurs. 
Molecular beacon 
The dual-labeled Molecular beacon probe is similar to the hydrolysis probe but it forms 
a hairpin structure because of short complementary sequences at both ends of the 
probe. The hybridization of the complementary sequences forces the probe into stem-
loop structure and the fluorophore and quencher very close to each other and, 
therefore, the molecular beacon probes are generally more efficiently quenched than 
the Hydrolysis probes. The Molecular beacon probes can be used in PCR as Hydrolysis 
probes and be degraded by the 5´ nuclease activity of the DNA polymerase, but they 
can also be used without degradation because the hybridization of the probe to the 
target sequence leads to the linearization of the probe and therefore, increased distance 
between the fluorophore and quencher leading to increased fluorescence signal. Thus, 
the Molecular beacon method can be used together with DNA polymerases lacking the 
5´ nuclease activity and also for direct single-stranded nucleic acid detection. 117 
(Figure 9) 
 
Figure 9. Principle of the Molecular beacon method. The stem-loop structure is linearized by 
the hybridization of the probe into the target sequence leading to an increased distance between 
the fluorophore (white circle) and quencher (black circle). The decreased quenching is observed 
in fluorescence signal increase. Modified from the reference 132. 
Numerous different applications utilizing the Molecular beacon hairpin structure have 
been introduced since introduction of the original method in 1996. The applications are 
mainly based on a primer containing the Molecular beacon probe at the primer's 5´ end 
as an overhang tail. The integration of the primer and probe simplifies the assay 
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because a separate probe oligonucleotide is not needed. The Amplifluor method 118 was 
the first system joining the Molecular beacon probe and primer. In that system the 
fluorophore is quenched because the hairpin structure brings the quencher and 
fluorophore in close proximity just as in common Molecular beacon probe. When a 
DNA polymerase copies the 5´ tail overhang sequence incorporated to the amplicon the 
hairpin structure is linearized and the quenching is released. Another method, the 
Scorpion primer 119, 120 is a similar primer probe fusion as the Amplifluor but it has also 
a nonamplifiable monomer, for example, hexaethylene glycol (HEG) in the junction of 
the primer and probe that blocks the DNA polymerase amplification of the primers 5´ 
tail containing the probe sequence with the fluorophore and quencher. In addition, the 
scorpion primers 5´ tail loop has a target-recognizing sequence. During PCR 
amplification the scorpion primer initiates the amplification and is incorporated to the 
synthesized strand. The following denaturation and annealing steps lead to the self-
hybridization of the probe sequence to the target sequence at the 5´ tail into the same 
strand and therefore, to an increased fluorescence signal by the released quenching. 
Molecular beacon-based universal probe systems have also been developed. The 
UniPrimer system 121 is similar to the Amplifluor method but it involves the usage of 
additional primer containing a 5´ overhang recognition sequence for the primer probe 
fusion. The primer with a 5´ recognition site first initiates the target amplification and is 
incorporated to the amplified target. Then the UniPrimer hybridizes to the amplified 
strand and is incorporated to the amplicon and the UniPrimer functions as the Amplifluor 
primer (described in the previous chapter). In another universal system introduced by Li et 
al. 122 a common Molecular beacon probe hybridizes to the primers 5´ overhang sequence 
and is therefore linearized and unquenched. During the PCR the primers are incorporated 
to the amplified target and the hybridized molecular beacon probes are displaced by the 
DNA polymerase enzyme lacking the 5´ nuclease activity. The unhybridized probes form 
a hairpin structure and are quenched and therefore, a fluorescence signal decrease instead 
of an increase in the presence of the target is observed. 
Universal detection systems may simplify assay development but specificity of the 
introduced systems is based only on the primers; they are, therefore, prone to false 
positive results due to unspecific amplification initiated by the primers. Recently, 
Faltin et al. 123  introduced a universal Mediator probe PCR that avoids false signal 
generation originated from unspecific amplification. The Mediator probe is an 
oligonucleotide probe that hybridizes to the target sequence between two PCR primers. 
The probe contains a 5´ overhang that is cut apart from the target recognizing 3´ end by 
the 5´ nuclease activity of the DNA polymerase during the PCR amplification. The 
released 5´ tail is called the Mediator and it hybridizes to the universal reporter probe 
in the reaction solution. The universal reporter probe is a Molecular beacon probe with 
3´ overhang sequence complementary to the Mediator and the intact probe is in a 
hairpin structure and quenched. The Mediator hybridization to the 3´ tail of the reporter 
creates a free 3´ primer end for the DNA polymerase and the polymerase then 
amplifies the universal probe sequence. During the amplification the DNA polymerase 
also degrades the probe's hairpin loop from the 5´ end and/or displaces the hairpin 
structure leading to released quenching. 
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Adjacent hybridization probes 
The Adjacent hybridization probes, also called the FRET probes, consist of two 
oligonucleotide probes that hybridize one after another to the target sequence. Both 
probes are commonly end-labeled (one probe at the 5´ and the other at the 3´ end) with 
fluorophores in a way that the hybridization of the probes brings the fluorophores in 
close proximity. The FRET between the fluorophores occurs and the emission of the 
acceptor can be measured when the probes are hybridized. The Adjacent hybridization 
probes can be used for the measurement of the amplified (e.g., by PCR) DNA and also 
for the melting curve analysis. 102 (Figure 10) 
 
Figure 10. Principle of the Adjacent hybridization probe technology. The hybridization of the 
probes into adjacent positions brings the donor (gray circle) and acceptor (white circle) 
fluorophores in close proximity. The acceptor's fluorescence signal increases when the energy 
transfer occurs. Modified from the reference 132. 
Competitive hybridization 
The Competitive hybridization method involves the use of two complementary 
oligonucleotide probes. One probe carries a fluorophore, for example, at the 3´ end and 
the other a quencher at the 5´ end. In the absence of a target the probes are hybridized 
and the fluorescence is quenched. In the presence of the target sequence, for example, a 
PCR amplification product the fluorescent probe hybridizes to the target resulting in an 
increased fluorescent signal. 124, 134 (Figure 11) 
 
Figure 11. Principle of the Competitive hybridization method. Increased fluorescence signal is 
observed when the fluorophore (white circle) labeled probe hybridizes to the target sequence 
leading to increased distance between the fluorophore and quencher (black circle).  
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Fluorescent lanthanide chelate-labeled probes have been used in homogenous PCR 
assays based on the Competitive hybridization method and the fluorescent probe 
hybridization into the target sequence has been increased by using a shorter or only 
partially complementary quencher probe that decreases the hybridization efficiency of 
the quencher probe towards the fluorescent probe 48, 135. Asymmetric PCR has been 
used to produce a ssDNA target product, that enables more effective fluorescent probe 
hybridization to the target strand 53. Another system utilizing fluorescent lanthanide 
probe and the competitive hybridization method has combined also the 5´ nuclease 
activity of the DNA polymerase to degrade the fluorescent probe hybridized to the 
target. The probe degradation leads to the accumulation of the released fluorophore to 
the reaction solution and, therefore, this system can provide a more efficient 
fluorescent signal increase 57. 
Other methods 
The Lion probe method is similar to the Hydrolysis probe technology but it utilizes 
DNA polymerase 3´ exonuclease activity. A dual end-labeled probe (fluorophore and 
quencher) contains a mismatch nucleotide at the 3´ end. When the probe is hybridized 
to the target strand the unpaired labeled 3´ end nucleotide is cut off by DNA 
polymerase enzyme 3´ nuclease activity. 129 
Another system called QZyme is based on a primer carrying an inactive DNAzyme 
sequence as a 5´ overhang and a dual end-labeled (fluorophore and quencher) 
oligonucleotide probe containing a QZyme substrate. During PCR, the primer's 5´ 
overhang sequence is incorporated to the amplicon and the complementary sequence is 
a catalytically active DNAzyme. The dual labeled substrate probe hybridizes to the 
active DNAzyme sequence and is cleaved at the substrate site. 125 
The NuPCR is similar to the Qzyme but it is based on two DNA Partzyme 
oligonucleotides and a universal dual end-labeled oligonucleotide substrate probe. The 
DNA Partzyme oligonucleotides hybridize to adjacent positions into the nucleic acid 
target, for example, to the PCR amplified target sequence, and form a NuZyme nucleic 
acid enzyme that recognizes the substrate probe and cleaves the probe releasing the 
fluorophore and quencher molecules in two separate units. 126 
Yamane et al. 127 have introduced the MagiProbe method where a single dual labeled 
oligonucleotide probe contains a fluorescein and a pyrene coupled to adjacent 
nucleotides in the middle of the probe. The pyrene quenches the signal of the free 
probe in the solution. When the probe is hybridized to the target sequence the pyrene is 
intercalated into the DNA complex decreasing the quenching and leading to 
fluorescence signal increase. The MagiProbe method is suitable also for SNP detection 
as the fluorescence remains quenched because of an unhybridized pyrene labeled 
nucleotide. 
A fluorescent europium chelate donor and organic fluorophore acceptor based dual 
end-labeled Decay probe system has been published by Laitala et al. 136. The donor 
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and acceptor of the free Decay probe in the solution are located very close to each 
other because of natural conformation of the probe and, therefore, the energy transfer 
is highly efficient leading to intensive short-lifetime acceptor signal. When the 
Decay probe is hybridized to the target DNA the donor-acceptor distance is increased 
leading to less efficient energy transfer and prolonged acceptor fluorescence lifetime. 
2.3.2.2 Non-FRET-based hybridization methods 
Several homogenous sequence-specific non-FRET fluorescence-based nucleic acid 
detection methods are listed in Table 4 and introduced below. 
Table 4. Homogenous sequence-specific non-FRET nucleic acid detection methods 
 
Method 
 
 
Principle 
Light-up probe 137  Environmental sensitive fluorophore 
Environmental sensitive lanthanide probe 138  
HyBeacon™ probes 139  
Binary malachite green aptamer (MGA) 140  
BODIPY FL primer/probe 141 Quenching by guanine 
Smart probes 142  
Competitive reporter monitored amplification (CMA) 143 Other 
Excimer-forming  two-probe nucleic acid hybridization method 144  
Fluorescence polarization 145  
TPX technology 146  
Diamine catalyzed hemicyanine dye formation through DNA programmed 
chemistry 147 
 
Hybridization directed fluorescent complex formation 148  
Light-up probe 
In the Light-Up probe system a DNA intercalative fluorescent thiazole orange (TO) 
cyanine dye is coupled to a peptide nucleic acid (PNA) probe. PNA shows increased 
thermal stability and, in general, PNA-DNA complexes are more stable than DNA 
duplexes. When the Light-Up probe hybridizes to the target strand the TO dye is 
forced to bind to the DNA increasing the TO dye fluorescence. Signal intensity 
increase up to 50-fold due to the probe hybridization has been reported. The Light-
Up probe is a simple and promising method for homogenous nucleic acid detection 
but the functionality has not been demonstrated in homogenous nucleic acid 
amplification assay. This raises a question of the technology's suitability to real 
applications where the amplification needs to be performed in the same closed 
reaction. 137, 149 (Figure 12) 
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Figure 12. Principle of the Light-Up probe technology. The signal of the fluorophore increases 
when the probe is hybridized to the target sequence leading to the intercalation of the 
fluorophore. Modified from the reference 137. 
Environmental sensitive lanthanide probe 
The method is based on oligonucleotide labeled at its 5´ end with a TbIII chelate 
sensitive to its immediate chemical environment. The fluorescence of the used TbIII 
chelate is decreased when it is coupled to the oligonucleotide. The hybridization of the 
probe to the target sequence in PCR leads to the probe degradation by the DNA 
polymerase 5´ nuclease activity and to the release of the TbIII chelate to the reaction 
solution. The detachment of the TbIII chelate increases its fluorescence signal. 138, 150 
(Figure 13) 
 
Figure 13. Principle of the Environmental sensitive lanthanide probe technology. The 
hybridized probe is degraded during the PCR amplification by the DNA polymerase enzyme 
and the detachment of the lanthanide chelate (star) leads to increased fluorescence signal. 
Modified from the reference 138. 
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Competitive reporter monitored amplification (CMA) 
The CMA system is based on a capture probe array and fluorophore labeled reporter 
probes. The reporter probes are complementary to the capture probes and also to the 
amplified target nucleic acid. The binding of the reporter probes to the capture probes 
decreases with increasing amplification product concentration, and the fluorescence 
signal from the capture probe spot decreases during real-time detection of the 
amplification reaction. Reporter probe-target sequence hybrids in the solution are 
mechanically removed from the capture spot area by compressing the reaction chamber 
before the measurement to avoid background signal from the hybrids and from the free 
fluorescent probes. After measurement the reaction chamber is allowed to uncompress 
and the reaction solution is allowed to return to the measurement area. 143 (Figure 14) 
 
 
 
 
  
 
Figure 14. Principle of the Competitive reporter monitored amplification method. Fluorescent 
reporter probes hybridize to the amplified target sequences (A→C). The target-probe hybrids 
(and also free reporter probes) are removed from the measurement area by compressing the 
reaction chamber in the spot area (not illustrated in the figure). Multiplexed detection can be 
performed by spatial separation using different capture probes (a, b, c and d) and reporter 
probes in one reaction. Modified from the reference 143.  
Excimer-forming two-probe nucleic acid hybridization method 
The Excimer-forming method utilizes two oligonucleotide probes, one 5´ and other 3´ 
pyrene labeled. The hybridization of the probes to the adjacent positions on the target 
DNA brings the pyrenes in close proximity and leads to excimer formation as well as 
an emission shift to longer wavelengths (pyrene monomer and excimer emission band 
maximum wavelengths 378 nm and 495 nm, respectively). The distance of the pyrenes 
must be 3–4 Å; therefore, the excimer formation requires precise hybridization of the 
two probes. 144 (Figure 15) 
A B C 
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Figure 15. Principle of the Excimer-forming two-probe nucleic acid hybridization method. Two 
pyrene-labeled probes (P3 and P5) hybridize to adjacent positions into the target sequence and 
form an excimer with a fluorescence signal at a higher wavelength than the pyrene residues. 
Modified from the reference 151. 
Several DNA detection applications based on excimer formation have been published 
but there are no publications describing nucleic acid amplification and excimer-based 
detection performed in a homogenous reaction. However, a system combining a signal 
amplification method called hybridization chain reaction 152 and excimer formation has 
been introduced 153. The introduced method utilizes two oligonucleotide hairpin probes 
that contain pyrene dyes at both ends. The hairpin is formed in a way that the labeled 
ends are not in close proximity and thus, the excimer is not formed. Target DNA 
hybridizes to one of the labeled oligonucleotides leading to the opening of the hairpin 
structure and initiation of hybridization events. This results in a nicked double-helix 
structure where the 5´ and 3´ pyrenes from different probes are in close proximity 
forming excimers and, therefore producing a typical emission wavelength shift. 
Fujimoto et al. 154 have presented a Molecular beacon probe type hairpin probe 
containing pyrene dyes at both ends of the probe. The probe in the hairpin structure 
emits excimer fluorescence and when the probe is hybridized to the target the pyrenes 
are separated and excimer signal decreased.       
Fluorescence polarization 
The fluorescence polarization (FP) method is based on a target-specific oligonucleotide 
probe that is labeled with a fluorophore. The target's presence can be measured when 
the polarization of the emission fluorescence changes due to the hybridization of the 
probe to the target sequence. The fluorophore is excited with polarized light and the 
rotation of the excited unhybridized probe causes emission fluorescence depolarization. 
When the probe is bound to the target the fluorescence is more polarized because the 
larger probe-target hybrid rotates slower than free probe in solution. 24, 145, 155      
Fluorescence polarization has been used in different PCR amplification-based assays. 
For example, Gibson et al. 156 utilized fluorescent probe hybridization and FP 
measurement together with the amplification refractory mutation system for 
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genotyping. Another method reported by Latif et al. 157 used DNA polymerase 5´ 
nuclease activity to degrade a fluorescent probe hybridized to the amplified target 
sequence and FP detection. An intact fluorescent probe has a higher FP value than a 
cleaved probe and this difference was used for the genotyping of single nucleotide 
polymorphisms. Zhang et al. 158 have developed a target assisted exonuclease III-
catalyzed signal amplification fluorescence polarization method where Exo III 
enzyme's 3´ nuclease activity degrades a hybridized fluorophore-labeled probe. In this 
system the target DNA is not amplified but the fluorescent probes, one by one, 
continuously hybridize to the target DNA and are degraded, which leads to a change in 
the FP value. 
ArcDia TPX technology 
This technology is based on microparticles and two-photon excitation-based 
measurement. The microparticles are used as a solid phase for a single-base extension 
(SBE) reaction to concentrate the nucleic acid analyte and fluorescent dideoxy 
nucleotides on the surface of the particles. In single-nucleotide polymorphism (SNP) 
analysis the microparticles are coated with target-specific primers that hybridize next 
to the polymorphism site. During the SBE reaction the DNA polymerase incorporates a 
terminating dideoxynucleotide (ddA, ddT, ddC or ddG). One of the four 
dideoxynucleotides, the dideoxynucleotide complementary to the nucleotide of interest, 
is labeled with an organic fluorescent dye suitable for two-photon excitation. In the 
measurement, the optical forces of the near-infra red laser brings the microparticle into 
diffraction-limited focal point of the laser illumination and only a very small area 
approximately the volume of 1 femtoliter, is excited. The signal from the 
microparticles can be distinguished from the background signal because the fluorescent 
dideoxynucleotides are concentrated on the microparticle's surface and, furthermore, 
the signal from the free fluorescent dideoxynucleotides in the reaction solution remains 
low because only a small volume containing individual microparticle is excited. The 
TPX technology provides an interesting alternative to the FRET-based methods but, for 
example, the SBE method is based on the incorporation of only one fluorescent dye to 
one target strand requiring a relatively high analyte concentration and, therefore a pre-
amplification of the nucleic acid sample in a separate reaction. 146, 159 
Hybridization directed fluorescent lanthanide complex formation 
This technology was first introduced in 1990 by Oser & Valet 148 and it involves the 
usage of two non-fluorescent oligonucleotide probes, one 3´ labeled with a non-
fluorescent lanthanide ion carrier chelate and another 5´ labeled with a light absorbing 
antenna chromophore. The hybridization of the probes to adjacent positions into the 
target sequence brings the reporter molecules in close proximity leading to the 
formation of a fluorescent lanthanide chelate complex. The fluorescent complex is 
formed by self-assembly of the chromophore and the LnIII carrier chelate. The 
interaction between the reporter moieties is based on the formation of coordination 
bonds between the LnIII and a light absorbing chromophore. The intercation is 
relatively weak and, therefore the free probes in the solution do not form fluorescent 
lanthanide complex. (Figure 16) The technology has shown high sensitivity (low 
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picomolar target concentration) in homogenous nucleic acid detection because the 
background fluorescence signal from unhybridized probes is low and the 
autofluorescence is avoided by using time-resolved measurement. 160-162  
 
Figure 16. Principle illustrating the Hybridization directed fluorescent lanthanide complex 
formation technology. The hybridization of two non-fluorescent probes to adjacent positions 
into the target sequence leads to the self-assembled formation of a fluorescent lanthanide 
chelate complex. 162 
2.3.3 Conclusions 
In conclusion, several different fluorescence-based methods for homogenous nucleic 
acid detection have been developed during the past 25 years. The FRET-based methods 
and, especially, the Hydrolysis probe technology are the most commonly used methods 
in homogenous nucleic acid assays, although some relatively simple non-FRET-based 
systems have been introduced. The hydrolysis probe method is well-known, has 
routinely been used for more than a decade and has proven to be a reliable and 
effective nucleic acid detection method. There is also software available for relatively 
easy and straightforward Hydrolysis probe design, and several companies provide low-
cost syntheses of the probes as a routine service. 
However, FRET-based methods have also limitations and drawbacks. In general, 
background signal levels of the Hydrolysis probe-based assays are relatively high 
because of imperfect fluorescence signal quenching. In general, FRET-based 
quenching efficiency decreases with an inceasing distance between the fluorophore and 
quencher. Hydrolysis probes are commonly dual end-labeled to ensure the separation 
of the two dyes by the probe degradation but that can lead to a relatively long 
fluorophore-quencher distance. Furthermore, the secondary structure of the probe 
might also affect the fluorophore-quencher distance and thus, the quenching efficiency. 
It has also been reported that different quenchers have different attraction to the 
fluorophore and this can lead to a difference in quenching efficiency because the 
attraction can pull some quenchers closer to the fluorophores causing increased 
quenching 163. Autofluorescence from the reaction tubes and, especially, from 
biological sample material increases the background signal level of the assays using 
common organic fluorophores with steady-state measurement and, therefore effective 
sample preparation is required for obtaining pure nucleic acid samples. High 
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background fluorescence results in a low signal-to-background ratio (S/B) that might 
reduce assay sensitivity. 118, 164, 165 Furthermore, multiplexing using different organic 
fluorophores is reported to be cumbersome because of the wide overlapping emission 
spectra of the different fluorophores. In multiplexed assays fluorophores with suitable 
emission spectra and narrow-band emission filters should be used and, additionally, 
software for the emission signal processing must be used to discriminate the correct 
signal from interfering overlapping fluorescence. 166 Multiplexed closed-tube 
microarrays have been developed by attaching Molecular beacon probes to a solid 
surface. The hybridization of the target nucleic acid linearizes the hairpin structure of 
the probe and leads to fluorescence signal increase. However, no closed-tube system 
containing nucleic acid amplification and molecular beacon probe microarray has been 
presented and it has been reported that the microarray systems based on the Molecular 
beacon probes suffer from high background fluorescence signal because of incomplete 
quenching. 167-169 
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3 AIMS OF THE STUDY 
The hybridization-directed fluorescent lanthanide complex formation method also 
called the complementation probe technology has shown high sensitivity in 
homogenous nucleic acid detection because of low background signal level and high 
specific fluorescence signal in the presence of the target. The idea of this study was to 
further improve the complementation probe technology and study the suitability of the 
method for homogenous PCR based nucleic acid diagnostics. Another aim was to study 
the performance of the method in different sample materials, for example, urine, blood 
and bacterial growth medium to be able to design assays using minimal sample 
preparation. Furthermore, the overall aim was to establish a complementation probe-
based homogenous PCR assay concept suitable for rapid and high-performance clinical 
diagnostics. 
More specifically the original publications (titles in bold) had following aims: 
I   High-performance closed-tube PCR based on switchable luminescence 
 probes 
To study the suitability and performance of the complementation probe 
technology in homogenous PCR diagnostics including the design and synthesis 
of a new thermostable lanthanide (EuIII) chelate. 
 
II Homogenous M13 bacteriophage quantification assay using switchable 
 lanthanide fluorescence probes 
To explore the potential of the complementation probe method for direct 
amplification-free target organism measurement by designing a rapid and 
homogenous bacteriophage quantification method. 
 
III Homogenous duplex polymerase chain reaction assay using switchable 
 lanthanide fluorescence probes 
To study the applicability of the complementation probe technology for rapid 
clinical nucleic acid diagnostics by developing a duplex Chlamydia 
trachomatis PCR assay compatible with a simple urine sample preparation. 
The work also included designing and synthesizing a new light absorbing 
antenna for TbIII. 
 
IV Closed-tube HLA-DQA1*05 PCR assay based on switchable lanthanide 
 fluorescence probes and simple dried blood sample punch preparation 
To study the performance of the complementation probe technology in 
genotyping by applying the method for homogenous HLA DQA1*05 PCR 
assay compatible with simple blood sample preparation. 
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4 MATERIALS, METHODS AND BACKGROUND 
The key points of the materials and methods of this study are presented here. More 
detailed descriptions are found in the original publications (I–IV). Short introductions 
and schematic figures are also found in the results and discussion section at the 
beginning of different chapters. 
4.1 Switchable lanthanide chelate complementation 
probe technology 
The principle of the lanthanide chelate complementation probe technology (Figure 16 
and Figure 17) based on two oligonucleotide probes, one carrying a non-fluorescent 
lanthanide chelate and another carrying a light absorbing antenna, was introduced over 
20 years ago 148. The method has been found to be sensitive (low picomolar detection 
limit) in homogenous nucleic acid detection 160, 162 and also a duplex assay based on 
EuIII and TbIII complementation probes for the detection of single-nucleotide 
polymorphism has been introduced 161. However, a homogenous nucleic acid 
amplification assay based on the complementation probes is, for the first time, 
presented in this study. 
 
Figure 17. Principle of the Complementation probes-based nucleic acid detection. The non-
fluorescent probes hybridize to the target DNA and form a fluorescent lanthanide chelate 
complex by the self-assembly of the reporter molecules. 
4.1.1 Lanthanide ion carrier chelates 
The first lanthanide chelate complementation probe assays used DTPA 
(diethylenetriaminepentaacetic acid) 148 and EDTA (ethylenediaminetetraacetic acid) 
derivates as lanthanide ion carrier chelates to couple the LnIII to the oligonucleotide 
probe 160, 161. Later, also N1-EuIII [N1-(4-isothiocyanatobenzyl)diethylenetriamine-
N1,N2,N3,N3-tetrakis(acetato)europium(III)] carrier chelate was used in the 
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complementation probe system 162.  DTPA and EDTA can form 8 and 6 coordination 
bonds, respectively, with the lanthanide ion and the N1-EuIII chelates the LnIII by 7 
coordination bonds 170. In contrast, homogenous PCR assays using on inherently 
fluorescent lanthanide chelates have been based on more stable 9-dentate chelates to 
ensure the binding of the LnIII in PCR conditions and to prevent H2O-based quenching 
58-61. 
In magnetic resonance imaging (MRI) chelated gadolinium ions are injected to the 
patient and used as a contrast agent. Free GdIII is highly toxic to humans but chelated 
GdIII is nontoxic and, therefore, stable chelates must be used in MRI. In MRI cyclic 
chelates based on octadentate DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic acid) structure are commonly used because cyclic chelates are, in general, 
more stable than linear chelates, e.g., N1-EuIII; therefore, the DOTA based chelates are 
safer and preferred in MRI. 171, 172 
We hypothesized that the previously used DTPA, EDTA and N1-EuIII would not be 
stable enough in the PCR reaction conditions and the LnIII would be released from the 
chelate in the PCR denaturation temperatures of 95–98 °C. Because the 
complementation probe technology requires the coordination of the light absorbing 
antenna molecule to the LnIII, stable 9-dentate chelates occupying all the LnIII 
coordination sites cannot be used. 
 
We designed and synthesized DOTA based cyclic heptadentate europium and terbium 
carrier chelates 7d-DOTA-EuIII and 7d-DOTA-TbIII [2,20,200-[10-(3-
isothiocyanatobenzyl)-1,4,7,10-tetraazacyclo-dodecane-1,4,7-triyl]tri(acetato)EuIII/ 
TbIII], that leave two coordination sites to be occupied by the antenna ligand. The 
syntheses of 7d-DOTA-EuIII and 7d-DOTA-TbIII were described in the articles 
published by Karhunen et al. 2011 173 and in the publication III, respectively, and they 
are illustrated in Figure 18. 
4.1.2 Light absorbing antenna ligands 
The light absorbing antenna ligand needs to form coordination bonds with the LnIII but 
the interaction with the lanthanide ion carrier chelate should not be too strong to cause 
a binding of the antenna ligand to the LnIII-carrier chelate in the absence of the target 
DNA and, therefore, unspecific fluorescence. Previously, a 3-dentate light absorbing 
antenna ligand for EuIII (EuIII antenna) [4-((isothiocyanatophenyl)ethynyl)pyridine-2,6-
dicarboxylicacid] based on the fluorescent 7-dentate europium chelate structure 
[2,2´,2´´,2´´´-[[4-[4-(-Isothiocyanatophenyl)ethyl]pyridine-2,6-diyl]bis(methylene 
nitrilo)]tetrakis(acetic acid)], published by Takalo et al. 1994 174 was used in the 
complementation probe system together with N1-EuIII 162. That system has shown good 
sensitivity (22 pM target DNA) with low background signal level and relatively high 
signal modulation leading to a high signal-to-background ratio of 1400 and a dynamic 
range of 4 orders of magnitude. 162 We decided to use the same EuIII antenna structure 
and it is illustrated in Figure 18. 
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EuIII and TbIII require different light absorbing antenna ligands because they have 
different lowest excited state levels as discussed earlier in chapter 2.1.2. Tridentate 
TMP-DPA [4-(2´,4´,6´-trimethoxyphenyl)pyridine-2,6-diyl]dicarboxylic acid)] 41 has 
been used in PerkinElmers (PerkinElmer Life and Analytical Sciences, MA, USA) 
heterogenous DELFIA (dissociation-enhanced lanthanide fluorescent immunoassay) 
technology as a TbIII enhancer. It has shown a millisecond TbIII fluorescence lifetimes 
and a relatively high quantum yield 41. A TMP-DPA derivative (TbIII antenna) [4-(3-[2-
(4-isothiocyanatophenyl)ethyl]-2,4,6-trimethoxyphenyl)-pyridine-2,6-dicarboxylic 
acid] containing an isothiocyanate coupling group was synthesized as described in 
publication III. The TbIII antenna is illustrated in Figure 18. 
 
Figure 18. Molecular structures of the complementation probe reporter molecules used in this 
study. 7d-DOTA-EuIII/TbIII lanthanide ion carrier chelate (1), EuIII antenna (2) and TbIII antenna 
(3). 
4.1.3 Preparation of the complementation probes 
The LnIII carrier probes were prepared by coupling the 7d-DOTA-EuIII (EuIII carrier 
probe) or 7d-DOTA-TbIII (TbIII carrier probe) to the 3´ end of the target-specific 
oligonucleotides. In addition, N1-EuIII was also used to be able to compare the 
functionality and thermostability of the 7d-DOTA-EuIII and N1-EuIII chelates. 
The antenna probes were prepared by labeling oligonucleotides at the 5´ end with the 
EuIII antenna (EuIII antenna probe) or with the TbIII antenna (TbIII antenna probe). The 
LnIII carrier probes and antenna probes were designed to hybridize to adjacent positions 
(leaving one unhybridized nucleotide between the two probes) into the target 
sequences bringing the labeled 3´ and 5´ ends in close proximity and hence, allowing 
the fluorescent lanthanide complex formation by self-assembly of the LnIII-carrier and 
antenna molecules. The design and preparation of the probes used in different assays 
are described in publications I–IV and the labeling protocol in publication I. 
4.1.4 The main methodologies and instruments 
All the measurements were performed using 50 nM probe concentrations if not 
otherwise mentioned.  Europium and terbium fluorescence signals were measured in 
time-resolved mode using a 340 nm excitation filter, and 615 nm and 545 nm emission 
filters for europium and terbium signal measurements, respectively (Eu TRF and Tb 
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TRF) with 0.4 ms delay and 0.4 ms measurement times. The measurement cycle was 
repeated 1000 times in a total measurement time of approximately 1 s. The 
fluorescence signal of the TaqMan probe was measured using a 485 nm excitation 
filter, 535 nm emission filter and 0.1 s measurement time. The measurements were 
performed with the PerkinElmers 1420 Victor Multilabel Counter. 
The fluorescence emission spectra and lifetimes of the lanthanide chelate complexes 
formed by the hydridization of the EuIII and TbIII complementation probes to the 
synthetic oligonucleotide targets (10 nM) were measured with a Varian Cary Eclipse 
fluorescence spectrophotometer (Varian Scientific Instruments, Australia). The 
emission spectrum of the TbIII mixed chelate complex (hybridized TbIII carrier and TbIII 
antenna probes) was measured using 325 nm excitation with 20 nm slit, 450–750 nm 
emission with 5 nm slit, 0.1 ms delay, and 0.4 ms measurement time; the emission 
lifetime was measured using 325 nm excitation with 20 nm slit, 545 emission with 20 
nm slit, 0.05 ms delay, and 0.05 ms scan gate. The emission spectrum and lifetime of 
the EuIII mixed chelate complex (hybridized EuIII carrier and EuIII antenna probes) were 
measured identically to the TbIII complex measurements; an emission spectrum from 
550 nm to 750 nm was measured and the emission lifetime was detected at 615 nm, 
however. 
PCR amplification reactions were performed using conventional PCR thermal cycler 
(PTC-200 DNA engine, MJ Research, MA, USA). Conventional commercial PCR 
reagent and buffers were used as described in publications I, III and IV. In real-time 
PCR the reaction plate was removed from the thermal cycler to the multilabel counter 
for measurement at each measurement point. Three parallel reactions were used in all 
the measurements, except the clinical samples were tested without parallel reactions. 
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5 RESULTS AND DISCUSSION 
5.1 Properties of the EuIII and TbIII complementation 
probes 
The terms EuIII and TbIII complementation probes refers to the EuIII carrier probe and 
EuIII antenna probe pair, and to the TbIII carrier probe and TbIII antenna probe pair, 
respectively. 
5.1.1 Fluorescence emission spectra and lifetimes of the EuIII and TbIII 
complementation probes 
The EuIII and TbIII complementation probes formed fluorescent complexes at the 
presence of the oligonucleotide target and yielded typical EuIII and TbIII emission 
spectra with the main emission peaks at 615 nm and 545 nm, respectively (EuIII 
complementation probes emission spectra and lifetime are unpublished data). The 
emission lifetimes of EuIII and TbIII complementation complexes were 0.9 ms and 1.0 
ms, respectively. (Figure 19) The increased fluorescence signal in the presence of the 
target oligonucleotide indicates a fluorescence LnIII complex formation by coordination 
bonds and long fluorescence lifetimes enabled the usage of time-resolved measurement 
in the assay applications. 
 
Figure 19. Fluorescence emission spectra and lifetimes of the (A) EuIII and (B) TbIII complexes 
formed by the hybridization of the EuIII and TbIII complementation probes into the synthetic 
oligonucleotide target (black line) and in the absence of the target (grey dotted line). Lifetimes 
of the EuIII and TbIII main emission peaks at 615 nm and 545 nm, respectively, shown in insets. 
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5.1.2 Performance in closed-tube nucleic acid detection 
The nucleic acid detection performances of the EuIII and TbIII complementation 
probes were studied in homogenous hybridization reactions. The reactions contained 
either EuIII complementation probes or TbIII complementation probes and different 
concentrations of complementary synthetic oligonucleotide target. The probes 
hybridized to the target oligonucleotide and formed a fluorescent complex as 
illustrated in Figure 17. Fluorescence signal (Eu TRF or Tb TRF) was measured after 
5 min incubation at 22 °C. The performance tests are described in more detail in 
publications I (EuIII complementation probes) and III (TbIII complementation 
probes). 
Both the EuIII and TbIII complementation probes showed similar nucleic acid 
detection performances. Detection limits of 15 pM and 10 pM oligonucleotide target 
concentrations for EuIII and TbIII complementation probes, respectively, were 
measured. Both assays showed a dynamic range over three orders of magnitude and a 
high signal-to-background ratio; up to 1000 for EuIII complementation probes and 
800 for TbIII complementation probes. Results are illustrated in Figure 20. 
 
Figure 20. Standard curves of the (A) EuIII and (B) TbIII complementation probes based DNA 
detection using 50 nM probe concentrations (publications I and III, respectively). 
Other homogenous nucleic acid detection methods, e.g., a FRET-based Adjacent 
hybridization probes assay (principle of the technology introduced in the chapter 
2.3.2.1) with nucleic acid detection sensitivity of 200 pM has been reported using 
streptavidin containing several biotinylated europium chelates as a fluorescent donor 
and a Cy5 acceptor 175. Detection sensitivity of 30 pM has been reported using a 
similar Adjacent hybridization probes-based assay system with terbium chelates and 
Cy3 as a donor and acceptor, respectively 176. In addition, the Competitive 
hybridization probe system (introduced in chapter 2.3.2.1) with a fluorescein and 
quencher molecule has shown nucleic acid detection sensitivity of approximately 100 
pM with 10 min incubation time and 1 nM probe concentrations 124. In the same 
publication, a detection limit of 4 pM was reported using 6 h incubation time and low 
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concentrations (20 pM) of several probes hybridizing to separate sequences within the 
same target gene. Low probe concentrations were used to decrease the background 
signal level limiting the sensitivity but, at the same time the assay kinetics was affected 
making the system time-consuming and, therefore, impractical. 
5.1.3 Performance in homogenous PCR 
Thermal stability of the complementation probes 
Nucleic acid assays commonly require target amplification to increase the target 
concentration up to the detection range of the detection methods and, hence, in closed-
tube assays the nucleic acid detection method must be compatible with the 
amplification techniques. Most commonly the target nucleic acids are amplified using 
the polymerase chain reaction requiring relatively high temperature. Many sensitive 
nucleic acid detection methods, e.g., the Adjacent hybridization probes assays based on 
a europium and terbium-labeled streptavidin donor 175, 176, mentioned in the previous 
chapter, would most likely be dysfunctional in PCR reaction conditions because of the 
denaturation of the streptavidin in high temperature. 
The performance of the complementation probes in PCR reaction conditions, 
especially the thermostability of the new cyclic 7d-DOTA-LnIII carrier chelate needed 
to be studied before applying the technology to PCR assay applications. 
Thermostability was tested by cycling the temperature of the reaction containing EuIII 
complementation probes and 10 nM synthetic oligonucleotide target concentration 
between 30 °C and 98 °C for 30 cycles and measuring the Eu TRF at 30 °C after 30 s 
incubation in every cycle. To compare the effect of the lanthanide chelate structure on 
the thermostability, the non-cyclic N1-EuIII carrier chelate was also used in this study. 
The testing process is more precisely described in publication I. 
In the first cycle of the thermostability testing the reaction temperature was held at 98 
°C for 2 min as is usual at the beginning of the PCR during the initial denaturation 
step. The Eu TRF signal from the EuIII complementation probes noticeably decreased 
when measured after the first incubation at 98 °C; the following incubations at 98 °C 
decreased the Eu TRF signal only moderately and, therefore, it was concluded that the 
EuIII complementation probes were suitable for homogenous PCR. The Eu TRF from 
the complementation probes using N1-EuIII carrier chelate was dramatically decreased 
when measured after the first incubation at 98 °C, and during the following 10 
temperature cycles the signal was completely decreased to the background 
fluorescence signal level. The results are shown in Figure 21. 
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Figure 21. Thermal stability of the EuIII complementation probes. Reactions containing the EuIII 
antenna probe and  EuIII carrier probe labeled with the 7d-DOTA-EuIII carrier chelate (circles) 
or with N1-EuIII carrier chelate (square) and 10 nM synthetic oligonucleotide target (black 
symbols) or no target (white symbols). Temperature was cycled between 30 °C and 98 °C and 
Eu TRF measured in every thermal cycle at 30 °C. (publication I) 
Homogenous real-time PCR 
Various closed-tube PCR assays have been introduced in recent years, especially for 
the detection of infectious diseases. Both qualitative and quantitative PCR assays are 
useful, for example, in clinical infectious diseases diagnostics and both assays have 
been developed. Qualitative assays are sufficient, for example, for the detection of 
pathogenic bacteria such as Chlamydia trachomatis and Neisseria gonorrhoeae which 
are not a part of the normal human bacterial flora and thus, should not be found in the 
samples of healthy persons. Like the qualitative assays, real-time quantitative PCR 
assays can also be used for the detection of pathogenic microbes, but they can also be 
used, for example, to determine disease severity by quantifying the pathogenic microbe 
load in a clinical sample and to follow the efficiency of drug treatment, e.g., in HIV 
patients. The qPCR can also be used to differentiate between pathogenicity and 
commensalism when the target bacterium is a part of the normal human bacterial flora. 
18, 177, 178 
The nucleic acid detection performance of the complementation probe technology in 
homogenous PCR was studied and demonstrated by designing EuIII complementation 
probes and primers specific to synthetic oligonucleotide target as described in 
publication I. The PCR protocol consisted of 10 amplification cycles without 
measurement steps followed by 34 amplification cycles with the real-time Eu TRF 
measurements performed in every second cycle after 30 s incubation at 30 °C. The 
complementation probes based homogenous PCR assay principle is illustrated in 
Figure 22. The performance of the assay was compared to the Hydrolysis probe based 
homogenous PCR assay (method introduced in chapter 2.3.2.1) that is the most 
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commonly used closed-tube nucleic acid detection method. The Hydrolysis probe was 
designed to hybridize to the same target DNA as the complementation probes. The dual 
end-labeled probe contained a 6-carboxyfluorescein and a Black Hole Quencher-1. The 
same primers were used in both assays, whereas different DNA polymerase enzymes 
were used because 5´ nuclease activity is needed for probe degradation in the 
Hydrolysis probe assay, and in the complementation probe assay the degradation 
would lead to signal loss. Therefore, in the complementation probe PCR a DNA 
polymerase lacking the 5´ nuclease activity was used. The two assays are described in 
detail in publication I. 
 
Figure 22. Illustration of the complementation probes based homogenous real-time PCR. After 
a denaturation step at 98 °C the temperature (dashed line) is decreased to the measurement 
temperature of 30 °C. The non-fluorescent probes are hybridized to the target and a fluorescent 
complex is formed. Eu TRF is measured after 30 s of incubation and temperature is then raised 
to 72 °C for the target DNA extension step. The probes are designed to be unhybridized during 
the PCR amplification (temperatures 62–98 °C) and they hybridize only at low temperatures. 
The Complementation probe PCR assay showed a low background fluorescence signal 
level of approximately 1500 Eu TRF counts and a high specific signal level maximum 
of 390000 Eu TRF counts when the target DNA was amplified. The low background 
and high specific signal levels led to a very high signal-to-background ratio of 190–
300. The Hydrolysis probe-based PCR assay signal-to-background ratios were 
approximately 2 because of a relatively high background signal level approximately 
140000 6-FAM fluorescence signal. 
The PCR amplification efficiency of both assays was analyzed using standard curves 
where the base-10 logarithm of the initial template copy numbers and the 
corresponding threshold cycles were plotted on the x- and y-axis, respectively. The Ct 
numbers are inversely proportional to the base-10 logarithm of the initial template copy 
number 179. According to the standard curves, both assays showed similar and 
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appropriate amplification efficiency: the complementation probe PCR assay was 97.2% 
and the Hydrolysis probe based assay efficiency was 93.1%. The efficiency was 
calculated according to the equation: Efficiency = 10(-1/slope) 180, 181. The threshold cycle 
levels were detected approximately 6 amplification cycles earlier with the 
complementation probe method. A linear range of the Complementation probe-based 
PCR from 100 to 1 x 107 DNA template copies/reaction was measured but lower 
template copy numbers (10 and 1 copies/reaction) were detectable only occasionally. 
The Hydrolysis probe-based PCR yielded a detectable signal from the reactions 
containing a minimum of 1000 template copies, whereas reactions containing 100 
DNA template copies yielded no signal clearly detectable from the background signal. 
The real-time PCR results of the both assays are illustrated in Figure 23. 
 
 
 
 
 
 
Figure 23. Real-time PCR performance of the Complementation probe-based (square) and the 
Hydrolysis probe-based (circle) assays. (A) Signal-to-background ratio of real-time PCR using 
100–10000000 DNA template copies and (B) standard curve showing linear relationship 
between the log template copy numbers and threshold cycles. (publication I) 
The signal-to-background ratios of the Hydrolysis probe assays are commonly of 2–6. 
The distance between the fluorophore and quencher of the dual end-labeled Hydrolysis 
probes can be relatively long (20–30 nucleotides) and an increased distance decreases 
the FRET efficiency and, therefore, the quenching of the intact probe. Low quenching 
efficiency increases the background signal level and decreases the S/B. Higher signal-
to-background ratios of the FRET-based assays has been reported using shorter minor 
groove binding probes and the Molecular beacon probes. 164, 165, 182, 183 The highest S/B 
(35) of the FRET-based PCR assays have been reported using the Amplifluor method 
(introduced in chapter 2.3.2.1) that combines the Molecular beacon probe to the 5' end 
of the primer. The Molecular beacon method has shown better quenching efficiency 
than the Hydrolysis probe technology because the stem-loop structure brings the 
reporter moieties close to each other, but the stem-loop structure competes with the 
probe-target hybridization and thus, might decrease probe's hybridization efficiency to 
the target DNA. In the Amplifluor method the Amplifluor primer is linearized when 
the DNA polymerase replicates the primer sequence and the quenching is effectively 
released. 118 The Amplifluor method has clearly shown the highest S/B of the 
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homogenous FRET-based assays, but the ratio still remains almost 10 times lower than 
in the Complementation probe based PCR assay. 
5.2 Homogenous DNA detection assay applications based 
on the complementation probe technology 
Different homogenous nucleic acid assays were designed and developed to study and 
demonstrate the suitability of the complementation probe technology for PCR-based 
infectious disease diagnostics (III), PCR based genotyping (IV) and rapid 
amplification-free bacteriophage quantification (II). 
5.2.1 Chlamydia trachomatis duplex PCR assay 
Chlamydia infection caused by the bacterium Chlamydia trachomatis (Ct) is one of the 
most common sexually transmitted diseases (STD) 184. More than half of the infected 
persons are asymptomatic but if untreated the genital Ct infection can cause serious 
complications, e.g., pelvic inflammatory disease and infertility. Many infections 
remain undetected because asymptomatic persons do not seek to the STD testing and 
also because part of the tested individuals carrying the infection fail to return to the 
clinic for results and treatment. 185-187 
Nucleic acid amplification assays have shown higher sensitivity than the traditional 
culture and immunoassay-type C. trachomatis detection methods and the nucleic acid 
assays are currently considered as the golden standard in Ct diagnostics. The present Ct 
nucleic acid assays are mainly performed using urine samples and they have shown 
good performance with high sensitivity and specificity. However, the Ct assays 
commonly requires a multi-step urine sample preparation containing DNA extraction 
complicating the Ct diagnostics. Automated systems containing sample preparation and 
nucleic acid amplification with homogenous detection have been developed and are 
routinely used. The automated Ct assays are capable of diagnosing hundreds of assays 
in a work day but they are relatively expensive and usually located to central 
laboratories. The overall time from sample collection to treatment initiation is easily 
delayed by several days because the collected specimen is first transported to the 
analysis clinic, then analyzed among other samples and, finally, the patient needs to 
return to the doctor's practice for the prescription. 185, 188, 189 
A rapid, easy-to-use and reliable Ct assay providing results while waiting (maximum 1 
h) would be valuable for the prevention of Ct transmission, especially in resource-poor 
settings. Recently, an automated C. trachomatis nucleic acid amplification assay 
providing results in 90 min (including Neisseria gonorrhoeae analysis in the same 
reaction) was FDA approved (510(k) number K121710). Although, the system is 
flexible allowing the initiation of individual sample analyses at different times, the 
assay time still remains relatively long.  
A europium and terbium complementation probes-based homogenous duplex C. 
trachomatis PCR assay (complementation probe Ct assay) was developed by designing 
Results and discussion 
54 
primers and EuIII complementation probes specific to the Ct cryptic plasmid. C. 
trachomatis contains multiple plasmids, and, plasmid detection can be useful, 
especially for an early Ct infection diagnosis when a urine sample might contain a 
relatively small number of bacteria and it also allows more flexibility in sample 
preparation, for example, the use of more diluted samples. Internal amplification 
control (IAC) was created to confirm PCR functionality when no Ct-specific Eu TRF 
signal is observed (Ct negative reaction). Internal amplification control TbIII 
complementation probes specific to a certain sequence in the IAC target plasmid were 
designed (IAC plasmid and primers were presented previously 48) and the IAC target 
plasmid, IAC primers and IAC specific TbIII complementation probes were included in 
every reaction. The Eu TRF and Tb TRF signals were measured in every second PCR 
cycle starting at the cycle 10. Real-time measurement is not required in Ct diagnosis 
but it was performed to follow the functionality of the new complementation probe 
technology in the urine sample analysis and to determine threshold cycle numbers. The 
complementation probe Ct assay is described in detail in publication III and the assay 
principle is shown in Figure 24. 
 
Figure 24. Principle of the complementation probes based C. trachomatis duplex PCR assay. 
(publication III) 
Urine samples contain variable amounts of different organic and inorganic substances, 
e.g., ammonium and magnesium crystals that can decrease the PCR performance 190. 
Commonly, C. trachomatis DNA is extracted and the PCR inhibitors are removed in 
multistep urine sample preparation procedures. We used a 10 minute simple C. 
trachomatis bacterial concentration and washing procedure based on centrifugation. 
The Ct cells and epithelial cells containing Ct cells in the urine sample were 
concentrated on the bottom of the microcentrifuge tube by centrifugation; this step was 
followed by suspension (washing) of the cells and subsequent centrifugation. Washed 
Ct bacteria were resuspended in the water and used for PCR analysis. The urine sample 
preparation is described in publication III and previously by Lehmusvuori et al. 48. 
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Total of 100 urine samples were tested with the complementation probe Ct assay. As a 
reference, the same samples were also analyzed with the BD ProbeTec Ct ET assay 
(Becton Dickinson Diagnostic Systems, MD, USA) combined with the automated 
BUGSn BEADS STI-fast sample preparation (NorDiag, Oslo, Norway) 191, 192. The 
complementation probe Ct assay correlated 99–100% with the reference method 
showing good diagnostic accuracy. Both methods detected 50 Ct positive samples, 
while 1 urine sample (Ct negative according to the reference method) showed 
inhibition in the complementation probe Ct assay and no Tb TRF signal or Eu TRF 
signal was detected. In retesting the sample remained inhibitory, but when further 
diluted 1:1 to H2O Tb TRF a signal was detected and the sample was diagnosed as Ct 
negative. 
The positive urine samples mainly yielded very high Ct specific Eu TRF signal-to-
background ratios. A maximum S/B ratio of 244 was measured and 80% of the Ct 
positive samples gave a S/B ratio of over 70 while only 2 positive samples gave a S/B 
ratio below 6. The Ct negative urine samples yielded a maximum Eu TRF signal-to-
background ratio of 2. Because of the high S/B ratio difference between the positive 
and negative samples the complementation probe Ct assay result interpretation is clear. 
In 94% of the tested 50 Ct positive samples, the C. trachomatis-specific Eu TRF 
threshold were reached in cycle 26, at the latest, and all the Tb TRF threshold cycles of 
the Ct negative samples were reached by the cycle 24 (except in the inhibited reaction). 
The complementation probe Ct assay results of the analyzed 100 urine samples are 
shown in Figure 25. 
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Figure 25. Complementation probe Ct assay results of the analyzed 100 urine samples 
illustrated as the maximum Eu TRF and Tb TRF S/B ratios. C. trachomatis positive samples 
shown in red circles (n = 50) and Ct negative samples in green squares (n = 50) according to the 
reference method. The cut-off level defining the Ct status of the urine sample is shown as a 
dashed red line (sample Ct positive if Eu TRF exceeds the cut-off level of 3). Tb TRF cut-off 
level verifying the functionality of the assay when sample is Ct negative is shown as a green 
dashed line. * One sample was inhibitory, and after additional dilution gave a negative result 
correlating with the reference method. (publication III) 
According to 100 analyzed urine samples the complementation probe Ct assay 
performance was better than the performance of the previously presented homogenous 
rapid dry-reagent C. trachomatis PCR assay based on competitive hybridization and 
intrinsically fluorescent lanthanide chelates 48. In both assays the same urine sample 
preparation method was used. More inhibition was reported in the competitive 
hybridization based C. trachomatis assay (3 reactions from a total of 148 urine samples 
were inhibited, and 2 samples remained inhibitory also after additional dilution). 
However, only small numbers of urine samples were analyzed in both tests and 
different DNA polymerase enzymes, devices, and temperature profiles were used. 
Therefore, it cannot be concluded that the better performance was solely achieved due 
to the complementation probe technology. However, the complementation probe Ct 
assay seems to have a good performance and the technology allows urine sample 
analysis after simple sample preparation. 
Threshold cycles were reached relative early in the PCR amplification (mainly in 
cycles 24–26). Short amplification time would be beneficial for rapid nucleic acid 
diagnostics. The complementation probe Ct assay was performed by manually moving 
the reaction plate between the thermal cycler and measurement device making the 
assay time-consuming. For rapid Ct diagnostics the assay should be performed with 
automated thermal cycling containing a TRF measurement device, and without real-
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time measurement that is not required for qualitative measurement. The reagents 
should be in a self-contained package, for example, dried in the reaction chamber. 
Although the centrifugation-based sample preparation was relatively rapid, it requires 
some expertise as well as a centrifuge, and might be cumbersome especially for point-
of-care diagnostics. Instead of the centrifugation, a simpler alternative could be, for 
example, based on Ct bacteria concentration already during the sampling using the 
FirstBurst urine collector 193. The collector concentrates the Ct cells and, therefore, it 
might be possible to use a urine sample for analysis directly by only diluting the 
sample, assuming that the inhibitors are not concentrated during the sample collection. 
5.2.2 HLA-DQA1*05 PCR assay 
Increased sequence data due to the recent sequencing technology development have led 
to increased interest for genotyping, for example, using single-nucleotide 
polymorphism assays 194. Genotyping can be used to determine risk for certain human 
diseases, for example, genome-wide association studies have yielded evidence of 
genetic association to type 1 and 2 diabetes, Crohn´s disease and coronary artery 
disease 195, and also certain types of cancer have been linked to specific SNPs 196. 
Although a large number of SNPs have been identified, so far only a fraction of them 
have been linked to human diseases. Highly multiplexed whole-genome association 
studies are usually performed using heterogenous microarray-type chip-based methods 
197, 198. Homogenous FRET-based nucleic acid assays are commonly used to detect 
cases of a single or a few SNPs related to a known disease, for example, the Factor V 
Leiden point mutation linked to deep vein thrombosis 199. 
Different alleles in human leucocyte antigen (HLA) gene region have been shown to 
have an impact in about 50% of the cases of type 1 diabetes (T1D), and HLA-
DQA1*05 is one of the alleles used in T1D risk calculation. Type 1 diabetes is an 
autoimmune disease leading to pancreatic β cell destruction and, to a lack of (or 
insufficient) insulin production 200.  
A complementation probe HLA-DQA1*05 end-point PCR assay was developed to 
study the suitability of the complementation probes to detect single-nucleotide 
polymorphisms and to convert the routinely used (at the Immunogenetics Laboratory, 
University of Turku, Finland) heterogenous DELFIA technology-based HLA-
DQA1*05 PCR assay 201 to a homogenous format. A EuIII carrier probe and two 
different antenna probes specific to the HLA-DQA1*05 allele were designed. The 
antenna probes contained the polymorphism detection site (a minimum of two-
nucleotide difference between different alleles) and, therefore, the discrimination of the 
alleles was mainly based on the antenna probe hybridization. Because it is difficult to 
design an oligonucleotide probe specific only to the target sequence in a particular 
temperature using current oligonucleotide designing tools. Two different antenna 
probes with a two nucleotide difference in the sequence length (Antenna probe 1 with 
10 nucleotides and Antenna probe 2 with 12 nucleotides) were prepared as a fixed 
measurement temperature of 24 °C was used because of the requirements of the 
measurement device as well as practice limitations. The principle of the 
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complementation probe HLA-DQA1*05 end-point PCR assay is illustrated in Figure 
26. 
 
Figure 26. Complementation probe HLA-DQA1*05 PCR assay principle. The probes hybridize 
to the amplified target DNA at the measurement temperature of 24 °C forming a fluorescent 
lanthanide chelate complex. The allele discrimination is based on the antenna probe containing 
the polymorphism detection site. (publication IV) 
The allele discrimination power of the complementation probes was studied first in the 
homogenous hybridization assays containing the probes and two different synthetic 
single-stranded DQA1 allele sequences. The DQA1*05 target was complementary to 
the probes, while the DQA1*02 target had a two nucleotide difference at the 
polymorphism site. The probe and synthetic target sequences are shown in Table 5. In 
the hybridization assay both reactions containing the DQA1*05 target sequence and 
either the Antenna probe 1 or Antenna probe 2 gave a similar Eu TRF signal, but the 
longer Antenna probe 1 yielded a high Eu TRF signal also from the hybridization 
reaction with a non-target allele DQA1*02 (Figure 27). 
A melting curve analysis using the EuIII carrier probe, Antenna probe 1 (both 25 nM) 
and three different synthetic oligonucleotide targets (DQA1*05, DQA1*02 and 
DQA1*04) was performed to determine a suitable measurement temperature for the 
Antenna probe 1-based DQA1*05 detection. The melting curve analysis showed clear 
discrimination between the DQA1*05 and the two other alleles at temperatures 
between 30 and 39 °C. The results of the melting curve analysis are shown in Figure 
27. The assay set-ups are described in detail in publication IV. 
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Table 5. HLA-DQA1*05 PCR assay probe sequences and synthetic oligonucleotide target 
sequences (complementary target sequences shown in the table) used in the hybridization assay 
and melting curve analysis. 
 
 
 
 
 
 
 
 
Figure 27. Homogenous hybridization assay (A) and melting curve analysis (B) showing the 
ability of the HLA DQA1*05 complementation probes to detect the HLA DQA1*05 allele. (A) 
The EuIII carrier probe and Antenna probe 1 (boxes) or Antenna probe 2 (circles) hybridized to 
the synthetic DQA1*05 oligonucleotide (black solid line) and to the DQA1*0201 (gray dotted 
line) at the measurement temperature of 24 °C. (B) The EuIII carrier probe and Antenna probe 1 
hybridization to the synthetic oligonucleotide target DQA1*05 (green), DQA1*0201 (orange) 
and DQA1*04 (blue) in different temperatures. (publication IV) 
The complementation probe HLA-DQA1*05 end-point PCR assay was evaluated by 
testing 147 blood samples. The samples were collected on the protein saver cards 
(Whatman 903 Protein Saver Card, Maidstone, UK) and the DNA was liberated from 
the dried blood sample punches by rapid cell lysis treatment using high temperature 
and alkaline reaction conditions. After the lysis treatment the reaction was briefly 
centrifuged, and the supernatant was analyzed with the complementation probe HLA-
DQA1*05 PCR assay. The target DNA was PCR-amplified for 40 amplification cycles 
followed by Eu TRF measurement at the measurement temperature of 24 °C. The 
samples were also analyzed with the DELFIA technology based HLA-DQA1*05 PCR 
assay 201 that was used as a reference assay. The background Eu TRF signal level was 
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defined as the average signal from the non-HLA-DQA1*05 reactions (defined with the 
reference assay). 
The complementation probe HLA-DQA1*05 PCR assay correlated 100% with the 
reference assay; 88 samples were genotyped to the DQA1*05 allele. A signal-to-
background ratio up to 120, and an average S/B of 54 were measured. The results are 
illustrated inFigure 28.   
 
Figure 28. Complementation probe HLA-DQA1*05 end-point PCR assay results. The samples 
were genotyped as DQA1*05 allele and other DQA1 alleles according to the reference assay, 
and the S/B of the complementation probe HLA-DQA1*05 PCR assay is shown. A total of 147 
blood samples were analyzed, and 88 of them were typed as the HLA-DQA1*05 allele. The box 
presents the interquartile range (25–75%) and the whiskers determine the 5th and 95th 
percentiles. The circles and horizontal lines in the boxes denote the average and median, 
respectively, and the triangles show the minimum and maximum S/B values. 
One non-DQA1*05 sample yielded a Eu TRF S/B of 4.5 because one of the two 
parallel reactions gave a relatively high Eu TRF signal, although the sample was 
confirmed as non-DQA1*05 with the reference method (and also with other HLA-DQ 
genotyping assays, data not shown). The evaluation of the complementation probe 
HLA-DAQ1*05 PCR assay was performed in the laboratory where heterogenous PCR 
assays and inherently fluorescent europium probes are continuously used and, 
therefore, it is most likely that the signal of the one reaction was elevated because of an 
inherently fluorescent europium probe or PCR product contamination. 
Definite detection of the HLA-DQA1*05 was achieved with a clear discrimination to 
other DQA1 alleles. Signal generation in the complementation probe assay is very 
specific because it requires the hybridization of the two probes to adjacent positions 
into the target DNA. In addition, genotyping based on the complementation probes is 
depending only on the hybridization of the probes to the target DNA at adjustable 
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measurement temperatures (if a measurement device with an adjustable temperature 
is available). Therefore, probe designing is simple, and very short probes can be used 
when necessary for optimal discrimination, for example, in genotyping GC rich 
sequences. Commonly used single probe genotyping methods like, for example, the 
ones based on the Hydrolysis probe technology require probe degradation by the 
DNA polymerase enzyme during the PCR amplification. Thus, a relatively long 
probe able to hybridize in PCR elongation temperatures (typically 60–70 °C) must be 
used. In general, shorter probes have higher SNP discrimination efficiency than 
longer probes because one nucleotide difference has a greater effect on the 
hybridization of a shorter probe. Another commonly used genotyping method, the 
Molecular beacon, is based on the stem-loop linearization by the hybridization of the 
probe to the target sequence. The stem-loop formation competes with the probe-
target hybridization and can decrease the probe hybridization efficiency compared to 
the non-competitive methods. 
As the sequencing technologies keep developing and, especially, when the costs 
decrease the whole-genome sequencing might become a routine practice in healthcare. 
Genotyping with current single-nucleotide polymorphism assays might be replaced by 
simply sequencing the whole genome. However, in addition to the sequencing cost 
there are other limitations, for example, the analysis of the huge sequencing data 
amount with current computers; most likely it will take several years or even decades 
before the current SNP assays are replaced by sequencing in routine practice. Despite 
the improvements in sequencing technology, SNP assays will also be used in the 
future, e.g., to detect somatic mutations related to certain types of cancer. Tumor cells 
in the bloodstream can be detected because of the cancer specific mutation, and a 
measurement of the circulating cancer cell level, as well as the measurement of the 
cancer cell level change in the tumor during the treatment, can be used to evaluate the 
effect of cancer treatment. To be able to detect mutated cells among the high amount of 
wild type cells the detection method must be extremely specific and sensitive. The 
complementation probe technology is highly specific and should be suitable for 
detecting the tumor cells that represent only a minor proportion of the whole cell count, 
and this should be studied. 9, 202, 203 
5.2.3 Rapid amplification-free bacteriophage quantification assay 
Bacteriophages, also called phages, are bacteria-infecting viruses. In biotechnology 
they are used, for example, in protein engineering for the screening of large 
heterologous protein populations by a method called phage display. During a phage 
display, for example, when screening antibodies from large antibody libraries, the 
concentration of the bacteriophages needs to be determined. 204, 205 
The current ”gold standard” method for bacteriophage quantification is the plating 
method where bacterial cells are infected with a diluting series of phages and then 
plated on a selective agar plate containing antibiotics. After an overnight incubation the 
colonies are counted and the concentrations determined as colony forming units (cfu). 
Another commonly used bacteriophage quantification method is based on UV 
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photometry. Phages consist of protein and DNA and, therefore, light absorption of at 
265 nm can be used for phage quantification. The plating method is laborious and 
time-consuming, and the UV photometry-based method relatively unreliable as any 
impurities in the sample interfere with the measurement and, therefore, the 
bacteriophages should be purified using ultracentrifugation requiring a centrifugation 
time up to 36 h. 206-208 
A rapid bacteriophage quantification assay was created by designing a EuIII carrier and 
Antenna probes specific to a certain sequence in the M13 bacteriophage single-
stranded DNA phagemid. The assay was based on a quantitative detection of the M13 
bacteriophage ssDNA phagemid. A simple assay protocol was constructed. First, 
phages were lysed by incubating at 95 °C for 1 min. After phagemid liberation the 
temperature was cooled down to 25 °C where the probes were hydridized to the 
phagemid ssDNA, and the Eu TRF was measured. The assay can be used for the 
quantification of purified phage preparations and also for direct bacteriophage culture 
titer determination as illustrated in Figure 29. 
A complementation probe bacteriophage assay standard curve was created by first 
determining the infectivity titer (cfu/mL) of the M13 bacteriophage preparation using 
the plating method. Then, reactions containing a dilution series of the phages and the 
complementation probes (10 nM EuIII carrier and 5 nM antenna probe) were prepared, 
phages were lysed and Eu TRF measured as described previously. The suitability of the 
assay for direct bacteriophage culture quantification was demonstrated by culturing 
M13 bacteriophages and measuring the titer every second hour during a 20 h culture. A 
culture sample was withdrawn in every measurement point, the sample was prepared 
and Eu TRF measured as described in Figure 29. The Eu TRF signal was converted to 
cfu/mL by using the standard curve. The assay design and testing is described in more 
detail in publication II. 
    
Figure 29. Complementation probe bacteriophage quantification assay principle. In direct 
phage culture titer determination the bacteria are separated by centrifugation, and a sample from 
the supernatant containing the phages is 1:7 diluted in the assay buffer containing the 
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complementation probes. Phages are lysed in high temperature, followed by the hybridization of 
the probes to the target phagemid and Eu TRF measurement at 25 °C. (publication II) 
The standard curve showed a bacteriophage detection limit of 1.14 x 109 cfu/mL 
referring to similar low picomolar sensitivity reported previously. Parallel reactions 
yielded, on average, a 6.4% coefficient of variation showing good repeatability. The 
bacteriophage production monitoring was successful; in 4 h, the amount of phages had 
exceeded the assay detection limit, and the maximum phage titer was reached in 8–10 
h. (Figure 30) The phage culture quantification was performed in 20 min at each 
measurement point. 
 
Figure 30. Complementation probe bacteriophage quantification assay (A) standard curve and 
(B) monitoring of the phage culture during a 20 h culture. 
The bacteriophage quantification is based on the measurement of the phage ssDNA 
and, therefore, the phage size or the protein displayed on the surface of the phage, or 
impurities in the culture media that could cause variation in the absorbance-based 
measurement do not interfere with the complementation probes-based method. The 
same methodology could, most likely, be used for the quantification of any virus. The 
system could also be useful for the quantification of bacterial cultures when rapid and 
reliable results are needed and, or when the cultured bacteria tend to grow in clusters 
that would complicate the plating method-based quantification. 
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6 CONCLUSIONS 
In recent decades, especially in the past 10 years the number of new molecular 
diagnostic methods and assays has significantly increased. New genotyping methods 
have been introduced and the interest in microbial diagnostics has turned from 
traditional phenotypic methodologies towards faster genotypic technologies. The 
growing sequence databases and the need for faster (and more sensitive) microbial 
diagnostics have generated this trend. However, in practice the traditional methods 
relying, for example, on cultures are still the most commonly used procedures in 
microbe identification.  
The nucleic acid diagnostic assays for the detection of microbes causing infectious 
diseases will keep on developing and will most likely overcome the traditional culture-
based methods. But before ruling the microbial diagnostic markets the nucleic acid 
assays must become more cost-effective and even faster. This could be carried out, for 
example, by multiplexing the assays so that different pathogens causing similar 
symptoms could be detected in one reaction. The sample preparation should be rapid 
and simple to carry out or totally automated. Nowadays, one cause of delay in many 
healthcare districts is sample transportation from the sampling unit to the place of 
analysis because sophisticated automated nucleic acid amplification assays are mainly 
located in central laboratories. Affordable and rapid assays could also be used at small 
clinics and in resource-poor settings. Rapid and multiplexed high-performance assays 
would be ideal especially in urgent situations, e.g., in life-threatening bacteremia where 
an early identification of the microbe as well as antibiotic resistance detection would 
allow early start of the correct medication. In addition, the diagnostic platform should 
be flexible allowing individual sample analysis initiation at different times because at 
the moment samples are usually analyzed in a batch that is another major cause of 
delay of the analysis. 
In this study, the hybridization-directed fluorescence lanthanide complex formation 
method, here also called the switchable complementation probe technology, was 
further improved and applied to homogenous PCR diagnostics. Furthermore, 
theperformance of the complementation probe-based PCR concept for infectious 
disease diagnostics and for genotyping was evaluated. In addition, amplification free 
quantitative ssDNA virus detection was demonstrated. 
One of the main achievements of this study was the design and preparation of PCR-
compatible complementation probes that maintained their performance (fluorescence 
properties) in the PCR reaction conditions. This gave a basis for the PCR assay 
applications. The cyclic structure of the designed new heptadentate lanthanide ion 
carrier chelate created a cavity for the LnIII leading to a higher thermal stability 
compared to the linear lanthanide chelate. This showed that the lanthanide chelate 
stability is greatly related to the chelate structure and, therefore, it is possible to prepare 
stable lanthanide chelates without occupying all the LnIII coordination sites. The 
heptadentate lanthanide ion carrier chelate structure allowed fluorescent complex 
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formation by the coordination of the tridentate light absorbing antenna ligand to the 
LnIII and hence, an excitation energy transfer from the ligand to the lanthanide ion. A 
light absorbing antenna ligand for terbium was designed and synthesized and it allowed 
the preparation of duplex PCR assay. Two complementation probe pairs were required 
for a clinical assay where in addition to the target specific analysis an internal control 
is needed to monitor the assay functionality. (publications I & III)  
The complementation probes-based closed-tube PCR assays yielded a very high 
signal-to-background ratio. The high S/B ratio was achieved because of a low 
background signal level, and there were two main reasons leading to low background 
fluorescence. First, the long fluorescence lifetime of the lanthanides allowed usage of 
time-resolved measurement mode and, therefore, the measurement of 
autofluorescence was avoided. Second, the lanthanides are very poorly excited 
directly and they require an organic light-harvesting ligand coordinated to the LnIII 
for efficient excitation. The lanthanide ion carrier chelates and the respective ligand 
structures were inherently non-fluorescent causing no or only a minimal background 
signal. In addition, the non-specific binding of the probes or probe degradation do 
not lead to signal increase. (publications I & III) 
The PCR assays and the bacteriophage quantification method indicated that a simple 
and rapid sample preparation can be used with complementation probes-based assays. 
The complementation probe Ct assay with the simple 10 min urine sample preparation 
correlated 99–100% with the reference assay, and the complementation probe HLA-
DQA1*05 end-point PCR assay performed after simple DNA liberation from dried 
blood sample punches correlated 100% with the reference assay. Furthermore, the 
bacteriophage culture media was only diluted in the assay buffer containing the probes 
after the bacterial cells were separated from the phages by centrifugation. This leads to 
the conclusion that complementation probes-based high-performance nucleic acid 
assays can be developed using a simple sample preparation instead of the commonly 
used DNA extraction. Simple sample pretreatment should be relatively easy to 
automate creating a cost-effective system. (publications II, III & IV) 
Target DNA amplification by PCR using only slightly prepared samples has been 
proved to be successful previously and was proved to be efficient also in this study 48, 
201, 209. Nowadays, there are also DNA polymerase manufacturers providing so called 
direct PCR kits and it is stated that DNA can be amplified directly, for example, from 
several different human specimens, animal tissue and plants without DNA extraction. 
These different kits could be used together with the complementation probe technology 
for rapid diagnostics using different types of specimens. Although, the 
complementation probe technology-based assays showed that urine, blood and 
bacterial culture media are suitable to be used after a simple processing, the 
performance of the complementation probes in different sample materials, e.g., stool 
and sputum needs to be studied to find out what kind of samples can be analyzed 
directly. Different samples have different composition and, for example, stool samples 
are very heterogenous and the composition varies depending of the individual’s diet. 
The antenna molecules have carboxylic acid groups that are involved in the 
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coordination of the antenna ligands to the lanthanide ion carrier chelates. The antenna 
ligand might be vulnerable to samples containing high amounts of impurities that could 
be bound to the antenna by weak interactions preventing the fluorescent lanthanide 
complex formation. 
More multiplexed homogenous nucleic acid assays could be performed by applying 
samarium and dysprosium to the complementation probe technology with suitable 
antenna ligands. For example, the EuIII and TbIII antenna ligands should be functional 
with the SmIII and DyIII, respectively, because of similar energy levels. However, 
samarium and dysprosium have shorter emission lifetimes (SmIII 20–50 µs and DyIII 1–
20 µs) and lower fluorescence intensity than europium and terbium, and this would 
most likely lead to decreased nucleic acid detection performance in homogenous PCR 
compared to EuIII and TbIII complementation probes. 41, 63 Instead of using different 
lanthanides, highly multiplexed homogenous PCR assays could be prepared using one 
of the complementation probes (the lanthanide ion carrier probe or the antenna probe) 
as a capture probe by coupling it to the solid phase into the PCR reaction chamber. The 
capture probe and the other probe in the reaction solution would hybridize to the 
amplified target DNA and form a fluorescent lanthanide complex. A proof-of-principle 
complementation probe solid-phase array was recently published using synthetic 
oligonucleotide targets in a room temperature hybridization assay 210. A 
complementation probes based homogenous PCR microarray would allow the 
preparation of rapid high-performance multiplexed PCR assay applications. 
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